<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63333</article-id><article-id pub-id-type="doi">10.7554/eLife.63333</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cancer Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Estrogen receptor alpha in the brain mediates tamoxifen-induced changes in physiology in mice</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-209603"><name><surname>Zhang</surname><given-names>Zhi</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3222-2877</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund5"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209604"><name><surname>Park</surname><given-names>Jae Whan</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209605"><name><surname>Ahn</surname><given-names>In Sook</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146765"><name><surname>Diamante</surname><given-names>Graciel</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund6"/><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-222095"><name><surname>Sivakumar</surname><given-names>Nilla</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-146759"><name><surname>Arneson</surname><given-names>Douglas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-209606"><name><surname>Yang</surname><given-names>Xia</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con7"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-209607"><name><surname>van Veen</surname><given-names>J Edward</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-1798-3210</contrib-id><email>vanveen@ucla.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund4"/><xref ref-type="fn" rid="con8"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-208121"><name><surname>Correa</surname><given-names>Stephanie M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6221-689X</contrib-id><email>stephaniecorrea@ucla.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund4"/><xref ref-type="other" rid="fund7"/><xref ref-type="other" rid="fund3"/><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con9"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Department of Integrative Biology and Physiology, University of California Los Angeles</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Laboratory of Neuroendocrinology of the Brain Research Institute, University of California Los Angeles</institution><addr-line><named-content content-type="city">Los Angeles</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>McCarthy</surname><given-names>Margaret M</given-names></name><role>Reviewing Editor</role><aff><institution>University of Maryland School of Medicine</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Dulac</surname><given-names>Catherine</given-names></name><role>Senior Editor</role><aff><institution>Harvard University</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>03</month><year>2021</year></pub-date><pub-date pub-type="collection"><year>2021</year></pub-date><volume>10</volume><elocation-id>e63333</elocation-id><history><date date-type="received" iso-8601-date="2020-09-22"><day>22</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2021-01-25"><day>25</day><month>01</month><year>2021</year></date></history><permissions><copyright-statement>© 2021, Zhang et al</copyright-statement><copyright-year>2021</copyright-year><copyright-holder>Zhang et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63333-v1.pdf"/><abstract><p>Adjuvant tamoxifen therapy improves survival in breast cancer patients. Unfortunately, long-term treatment comes with side effects that impact health and quality of life, including hot flashes, changes in bone density, and fatigue. Partly due to a lack of proven animal models, the tissues and cells that mediate these negative side effects are unclear. Here, we show that mice undergoing tamoxifen treatment experience changes in temperature, bone, and movement. Single-cell RNA sequencing reveals that tamoxifen treatment induces widespread gene expression changes in the hypothalamus and preoptic area (hypothalamus-POA). These expression changes are dependent on estrogen receptor alpha (ERα), as conditional knockout of ERα in the hypothalamus-POA ablates or reverses tamoxifen-induced gene expression. Accordingly, ERα-deficient mice do not exhibit tamoxifen-induced changes in temperature, bone, or movement. These findings provide mechanistic insight into the effects of tamoxifen on the hypothalamus-POA and indicate that ERα mediates several physiological effects of tamoxifen treatment in mice.</p></abstract><abstract abstract-type="executive-summary"><title>eLife digest</title><p>Estrogen is a hormone often known for its role in female development and reproduction. Yet, it also has an impact on many biological processes such as immunity and the health of bones, the heart, or the brain. It usually works by attaching to receptor proteins in specific cells. For instance, estrogen-responsive cells are present in the hypothalamus, the brain area that controls energy levels as well as the body’s temperature and internal clock. Breast cancer cells are also often sensitive to estrogen, with the hormone fuelling the growth of tumors.</p><p>The drug tamoxifen blocks estrogen receptors, stopping cells from responding to the hormone. As such, it is often used to reduce the likelihood that estrogen-dependent breast cancer will come back after treatment. However, its use can induce hot flashes, changes in bone density, fatigue and other life-altering side effects.</p><p>Here, Zhang et al. investigated how estrogen receptors in the hypothalamus and a related region known as the preoptic area could be responsible for these side effects in mice. When the rodents were given tamoxifen for 28 days, they experienced changes in temperature, bone density and movement similar to those found in humans. In fact, genetic analyses revealed that the drug altered the way genes were turned on and off in certain cells types in the hypothalamus. Crucially, mice whose hypothalamus and preoptic area lacked estrogen receptors did not experience these behavioral and biological alterations.</p><p>The findings by Zhang et al. help to understand how the side effects of tamoxifen emerge, singling out estrogen receptors in particular brain regions. This result could help to develop new therapies so that breast cancer can be treated with a better quality of life.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>tamoxifen</kwd><kwd>hypothalamus</kwd><kwd>estrogen receptor alpha</kwd><kwd>thermoregulation</kwd><kwd>physical activity</kwd><kwd>bone</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000054</institution-id><institution>National Cancer Institute</institution></institution-wrap></funding-source><award-id>R21 CA249338</award-id><principal-award-recipient><name><surname>Correa</surname><given-names>Stephanie M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001368</institution-id><institution>V Foundation for Cancer Research</institution></institution-wrap></funding-source><award-id>V Scholar Award (V2017-007)</award-id><principal-award-recipient><name><surname>Correa</surname><given-names>Stephanie M</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id><institution>National Center for Advancing Translational Sciences</institution></institution-wrap></funding-source><award-id>Women's Health Pilot Project Grants in 2018 and 2019</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Zhi</given-names></name><name><surname>van Veen</surname><given-names>J Edward</given-names></name><name><surname>Correa</surname><given-names>Stephanie M</given-names></name></principal-award-recipient></award-group><award-group id="fund4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100006108</institution-id><institution>National Center for Advancing Translational Sciences</institution></institution-wrap></funding-source><award-id>UCLA CTSI (UL1TR001881)</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Zhi</given-names></name><name><surname>van Veen</surname><given-names>J Edward</given-names></name><name><surname>Correa</surname><given-names>Stephanie M</given-names></name></principal-award-recipient></award-group><award-group id="fund5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000968</institution-id><institution>American Heart Association</institution></institution-wrap></funding-source><award-id>18POST33960457</award-id><principal-award-recipient><name><surname>Zhang</surname><given-names>Zhi</given-names></name></principal-award-recipient></award-group><award-group id="fund6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000066</institution-id><institution>NIEHS</institution></institution-wrap></funding-source><award-id>T32ES015457</award-id><principal-award-recipient><name><surname>Diamante</surname><given-names>Graciel</given-names></name></principal-award-recipient></award-group><award-group id="fund7"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100001368</institution-id><institution>V Foundation for Cancer Research</institution></institution-wrap></funding-source><award-id>DVP2020-005</award-id><principal-award-recipient><name><surname>Correa</surname><given-names>Stephanie M</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Estrogen receptor alpha in the hypothalamus is required for the effects of chronic tamoxifen treament on gene expression, thermoregulation, bone, and movement in mice.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Tamoxifen is a selective estrogen receptor modulator that has been used for effective treatment of hormone responsive breast cancers for more than 40 years (<xref ref-type="bibr" rid="bib37">Jordan, 2003</xref>). As an adjuvant, tamoxifen therapy can decrease the incidence of breast cancer recurrence by up to 40% (<xref ref-type="bibr" rid="bib17">Davies et al., 2011</xref>). This exceptionally effective therapy remains standard of care for people with hormone-responsive cancers, and reduction of recurrence persists for at least 10 years of continuous tamoxifen treatment (<xref ref-type="bibr" rid="bib18">Davies et al., 2013</xref>; <xref ref-type="bibr" rid="bib13">Chlebowski et al., 2014</xref>; <xref ref-type="bibr" rid="bib29">Gierach et al., 2017</xref>). In contrast to these benefits, tamoxifen therapy has been associated with a variety of negative side effects, including increased risk for hot flashes (<xref ref-type="bibr" rid="bib54">Love et al., 1991</xref>; <xref ref-type="bibr" rid="bib34">Howell et al., 2005</xref>; <xref ref-type="bibr" rid="bib26">Francis et al., 2015</xref>), endometrial cancer and venous thromboembolic events (<xref ref-type="bibr" rid="bib25">Fisher et al., 1998</xref>; <xref ref-type="bibr" rid="bib15">Cuzick et al., 2007</xref>), bone loss (<xref ref-type="bibr" rid="bib70">Powles et al., 1996</xref>), and fatigue (<xref ref-type="bibr" rid="bib32">Haghighat et al., 2003</xref>). These responses markedly impact quality of life. Accordingly, ~25% of eligible patients fail to start or complete this life-saving therapy due to side effects and safety concerns (<xref ref-type="bibr" rid="bib27">Friese et al., 2013</xref>; <xref ref-type="bibr" rid="bib2">Berkowitz et al., 2021</xref>). The tissues and cells that mediate these negative side effects remain unclear. Unraveling the cells and mechanisms that mediate the positive effects of tamoxifen from those that mediate the negative side effects is necessary for understanding the multifaceted effects of tamoxifen therapy on physiology. Ultimately, this knowledge could lead to the design of new or adjuvant therapies that circumvent the side effects, improve patient quality of life, and perhaps enhance survival via increased patient compliance.</p><p>Within the brain, the hypothalamus and preoptic area (hypothalamus-POA) is highly enriched for estrogen receptor expression and represents an excellent anatomical candidate for mediating many of the side effects of tamoxifen therapy in humans. Estrogen receptor alpha (ERα) signaling regulates body temperature (<xref ref-type="bibr" rid="bib4">Bowe et al., 2006</xref>; <xref ref-type="bibr" rid="bib64">Musatov et al., 2007</xref>; <xref ref-type="bibr" rid="bib61">Mittelman-Smith et al., 2012</xref>; <xref ref-type="bibr" rid="bib57">Martínez de Morentin et al., 2014</xref>), physical activity (<xref ref-type="bibr" rid="bib64">Musatov et al., 2007</xref>; <xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>; <xref ref-type="bibr" rid="bib89">van Veen et al., 2020</xref>), and bone density (<xref ref-type="bibr" rid="bib23">Farman et al., 2016</xref>; <xref ref-type="bibr" rid="bib100">Zhang et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Herber et al., 2019</xref>) through distinct neuronal populations. Indeed, the hypothalamus-POA is a demonstrated target of tamoxifen, leading to changes in food intake and body weight (<xref ref-type="bibr" rid="bib91">Wade and Heller, 1993</xref>; <xref ref-type="bibr" rid="bib52">López et al., 2006</xref>; <xref ref-type="bibr" rid="bib46">Lampert et al., 2013</xref>) and changes in the hypothalamic-pituitary-ovarian (<xref ref-type="bibr" rid="bib94">Wilson et al., 2003</xref>; <xref ref-type="bibr" rid="bib1">Aquino et al., 2016</xref>) and hypothalamic-pituitary-adrenal (<xref ref-type="bibr" rid="bib94">Wilson et al., 2003</xref>) axes. Tamoxifen has also been shown to affect gene expression in the hypothalamus; its administration blocks the estrogen dependent induction of the progesterone receptor (<italic>Pgr</italic>) in the ventromedial hypothalamus (VMH) and increases the expression of estrogen receptor beta (<italic>Esr2</italic>) in the paraventricular nucleus of the hypothalamus (PVH) (<xref ref-type="bibr" rid="bib68">Patisaul et al., 2003</xref>; <xref ref-type="bibr" rid="bib1">Aquino et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Sá et al., 2016</xref>).</p><p>We hypothesized that tamoxifen alters estrogen receptor signaling in the hypothalamus-POA to mediate key negative side effects of tamoxifen therapy. To test this hypothesis, we modeled tamoxifen treatment in mice with a 28-day treatment course based on human dosage (<xref ref-type="bibr" rid="bib83">Slee et al., 1988</xref>) and asked if mice experience physiological effects similar to humans. We measured movement, bone density, and the temperature of the body core, tail skin, and thermogenic brown adipose tissue (BAT). Profiling genome-wide expression changes of individual cells in the hypothalamus-POA using Drop-seq, a droplet-based single-cell RNA sequencing technology, revealed transcriptional changes induced by tamoxifen in multiple cell types. Finally, we show that ERα expression in the hypothalamus-POA is necessary for the tamoxifen-induced chances in gene expression in the hypothalamus-POA and the effects on thermoregulation, bone density, and movement. Together, these findings suggest that tamoxifen treatment modulates ERα signaling in the central nervous system to alter fundamental aspects of physiology and health. Dissecting central versus peripheral effects and mechanisms of tamoxifen therapy is the first step toward identifying strategies to mitigate the adverse side effects of this life-saving treatment.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Tamoxifen treatment alters thermoregulation</title><p>To ask if mice and humans experience similar physiological effects while undergoing tamoxifen treatment, we administered tamoxifen (0.1 mg/kg) or vehicle subcutaneously, daily, for 4 weeks (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). In humans, hot flashes are characterized by frequent and sudden increases of heat dissipation from the face and other parts of the skin, often accompanied with perspiration and a decrease in core body temperature (<xref ref-type="bibr" rid="bib85">Stearns et al., 2002</xref>). Similarly, tamoxifen-treated mice showed significantly lower core body temperature compared to controls, as indicated by 24 hr averages from the last week of treatment (Sidak's Post-hoc: 24 hr p=0.0076, see <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref> for detailed statistics). This difference is detected during the light phase when the animals are generally inactive (Light: p=0.0003) but not in the dark phase (Dark: p=0.1164) when movement can also influence core temperature (<xref ref-type="fig" rid="fig1">Figure 1B and C</xref>). In mice, heat dissipation occurs effectively via vasodilation in the tail (<xref ref-type="bibr" rid="bib31">Gordon, 1993</xref>). As tail skin temperature is highly dependent on core and ambient temperature, heat loss is often expressed as the heat loss index (HLI): HLI = (Tskin − Tambient)/(Tcore − Tambient) (<xref ref-type="bibr" rid="bib75">Romanovsky et al., 2002</xref>). We observed a higher HLI in mice treated with tamoxifen compared to controls (<xref ref-type="fig" rid="fig1">Figures 1D and E</xref> and 24 hr: p=0.005). Again, this effect was detected in the light phase but not in the dark phase (<xref ref-type="fig" rid="fig1">Figure 1E</xref>, Light: p=0.0088, Dark: p=0.061). Tail skin temperature also was significantly higher in tamoxifen-treated mice compared to controls during light phase (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A and B</xref>, Light: p=0.0231, Dark: p=0.0968). In addition, mice treated with tamoxifen exhibited lower temperature above the intrascapular region directly apposed to BAT depots (<xref ref-type="fig" rid="fig1">Figure 1F and G</xref>, t = 3.255, df = 8, p=0.0116), suggesting reduced heat production from BAT following tamoxifen treatment. Accordingly, postmortem quantitative (q)PCR analysis of BAT revealed lower expression of genes associated with thermogenesis, uncoupling protein 1 (<italic>Ucp1</italic>) (t = 2.738, df = 16, p=0.0146) and adrenergic receptor beta 3 (<italic>Adrb3</italic>) (t = 2.732, df = 16, p=0.0148) (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1C</xref>), suggesting suppressed BAT thermogenesis and sympathetic tone following tamoxifen treatment (<xref ref-type="bibr" rid="bib9">Cannon and Nedergaard, 2004</xref>). Together, these results indicate that tamoxifen treatment shifts mouse temperature balance toward increased heat dissipation and decreased heat production, consistent with the observations in humans experiencing hot flashes.</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Tamoxifen treatment decreases core body temperature and increases heat dissipation.</title><p>(<bold>A</bold>) Strategy to measure the physiological and gene expression effects of long-term tamoxifen (Tmx) treatment. Mice were treated by daily subcutaneous injection of 0.1 mg/kg tamoxifen or corn oil for 4 weeks. Core and tail temperature were measured every 5 min using telemetry probes. Snapshot of thermographic images for brown adipose tissue (BAT) temperature was obtained in last week of treatment. At the conclusion of 4-week treatment, experimental mice were sacrificed for bone analysis or single-cell RNA sequencing. (<bold>B</bold>) Hourly average of core body temperature over 3 days before and 3 weeks after injections (dotted line). (<bold>C</bold>) Average core body temperature from mice shown in panel (<bold>B</bold>) highlighting per animal averages in light (7:00 to 19:00), dark (19:00 to 7:00), and total 24 hr periods (n = 8, treatment: F<sub>1,14</sub>=11.92, p=0.0039). (<bold>D</bold>) Heat loss index (HLI) calculated from continuous measurements of core and tail temperature. (<bold>E</bold>) Average HLI from mice shown in panel (<bold>D</bold>) (n = 7, treatment: F<sub>1,14</sub>=15.52, p=0.0015). (<bold>F</bold>) Thermographic images of interscapular skin above BAT depots in mice injected with either oil or tamoxifen. (<bold>G</bold>) Quantification of temperature of skin above interscapular BAT depots (n = 5, t<sub>8</sub> = 3.255, p=0.0116). In (<bold>B</bold> and <bold>D</bold>), line shading width represents standard error of the mean (SEM). ns, not significant, *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001 for Sidak’s multiple comparison tests (<bold>C and E</bold>) following a significant effect of treatment in a two-way repeated measures ANOVA or two-tailed t-tests (<bold>G</bold>).</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panel b.</title><p>Hourly average of core body temperature over 3 days before and 3 weeks after injections. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata2"><label>Figure 1—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panel c.</title><p>Average core body temperature in light, dark, and total 24 hr periods. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata3"><label>Figure 1—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panel d.</title><p>Hourly heat loss index (HLI) calculated from continuous measurements of core and tail temperature. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata4"><label>Figure 1—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panel e.</title><p>Average HLI over the light, dark, and 24 hr periods. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1sdata5"><label>Figure 1—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panel g.</title><p>Quantification of temperature of skin above interscapular brown adipose tissue (BAT) depots. Each row is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-data5-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig1-v1.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Tamoxifen increases temperature in tail and suppresses thermogenic gene expression in brown adipose tissue (BAT).</title><p>(<bold>A</bold>) Hourly average of tail skin temperature (T<sub>tail</sub>) over 3 days before and 3 weeks after injections (dotted line) measured every 5 min using attached thermal logger. (<bold>B</bold>) Average T<sub>tail</sub> from mice shown in panel (<bold>A</bold>) highlighting per animal averages in light, dark, and total 24 hr periods (n = 8, treatment: F<sub>1,14</sub>=12.87, p=0.003). (<bold>C</bold>) Relative mRNA expression from BAT (n = 8–10) of <italic>Ucp1</italic> (t<sub>16</sub> = 2.738, p=0.0146) and <italic>Adrb3</italic> (t<sub>16</sub> = 2.732, p=0.0148) following oil or tamoxifen (Tmx) treatment. ns, not significant; *, p&lt;0.05; **, p&lt;0.01 for Sidak’s multiple comparison tests (<bold>B</bold>) following a significant effect of treatment in a two-way repeated measures ANOVA or two-tailed t-tests (<bold>C</bold>).</p><p><supplementary-material id="fig1s1sdata1"><label>Figure 1—figure supplement 1—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, panel a.</title><p>Hourly average of tail skin temperature (T<sub>tail</sub>) over 3 days before and 3 weeks after injections measured every 5 min using attached thermal logger. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-figsupp1-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata2"><label>Figure 1—figure supplement 1—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, panel b.</title><p>Average T<sub>tail</sub> in light, dark, and total 24 hr periods. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-figsupp1-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig1s1sdata3"><label>Figure 1—figure supplement 1—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, panel c.</title><p>Relative mRNA expression from brown adipose tissue (BAT) of <italic>Ucp1</italic> and <italic>Adrb3</italic> following oil or tamoxifen (Tmx) treatment. Each row is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig1-figsupp1-data3-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig1-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-2"><title>Tamoxifen treatment increases bone density and decreases movement</title><p>Tamoxifen has been shown to affect bone density in rodent and human studies (<xref ref-type="bibr" rid="bib70">Powles et al., 1996</xref>; <xref ref-type="bibr" rid="bib69">Perry et al., 2005</xref>). Here, micro-computed tomography (microCT) scans revealed that tamoxifen treatment is associated with greater bone volume ratios in both metaphysis (t = 7.322, df = 10, p&lt;0.0001) and diaphysis (t = 3.557, df = 10, p=0.0052) of the femur (<xref ref-type="fig" rid="fig2">Figure 2A–C</xref>). Tamoxifen treatment was also associated with greater number (t = 7.539, df = 10, p&lt;0.0001) and thickness (t = 5.303, df = 10, p=0.0003), and less separation of trabecular bones (t = 7.331, df = 10, p&lt;0.0001) in metaphysis (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Bone mineral density (t = 0.09262, df = 10, p=0.928) and bone area (t = 1.368, df = 10, p=0.2013) in cortical bones were not significantly affected by tamoxifen treatment (<xref ref-type="fig" rid="fig2">Figure 2C</xref>); however, tamoxifen treatment was associated with significantly greater cortical thickness (t = 2.451, df = 10, p=0.0342) (<xref ref-type="fig" rid="fig2">Figure 2A and C</xref>). Together, these data indicate that chronic tamoxifen treatment increases bone mass, consistent with previous studies showing increased bone formation and bone mass in mice following tamoxifen administration (<xref ref-type="bibr" rid="bib69">Perry et al., 2005</xref>; <xref ref-type="bibr" rid="bib84">Starnes et al., 2007</xref>). In addition, tamoxifen resulted in a moderate decrease in 24 hr movement (t = 3.296, df = 42, p=0.006) (<xref ref-type="fig" rid="fig2">Figure 2D and E</xref>). Tamoxifen-treated mice did not show significant changes in body weight compared to control mice, over 28 days of treatment (treatment: p=0.5468) (<xref ref-type="fig" rid="fig2">Figure 2F and G</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Tamoxifen treatment increases bone density and decreases movement.</title><p>(<bold>A</bold>) Representative micro-computed tomography (microCT) images showing bone density of the distal metaphysis and midshaft diaphysis of femurs from tamoxifen or oil treated female mice. Tamoxifen or vehicle was injected subcutaneously at 0.1 mg/kg for 28 days. (<bold>B</bold>) Trabecular bone volume fraction (BV/TV, t<sub>10</sub> = 7.322, p&lt;0.0001), trabecular numbers (Tb.N, t<sub>10</sub> = 7.539, p&lt;0.0001), trabecular thickness (Tb.Th, t<sub>10</sub> = 5.303, p=0.0003), and trabecular separation (Tb.Sp, t<sub>10</sub> = 7.331, p&lt;0.0001) in distal metaphysis of femurs (n = 6). (<bold>C</bold>) Bone volume fraction (Ct.BV/TV, t<sub>10</sub> = 3.557, p=0.0052), cortical thickness (Ct.Th, t<sub>10</sub> = 2.451, p=0.0342), bone mineral density (Ct.BMD, t<sub>10</sub> = 0.0926, p=0.928), and cortical area (Ct.Ar, t<sub>10</sub> = 1.368, p=0.2013) in diaphysis of femurs (n = 6). (<bold>D</bold>) Hourly average of movement over 3 days before and 3 weeks after tamoxifen or oil injections (dotted line) measured every 5 min using an intraperitoneal telemetry probe. Line shading width represents standard error of the mean (SEM). (<bold>E</bold>) Average total movement from mice shown in panel (<bold>D</bold>) (n = 8, treatment: F<sub>1,14</sub>=6.182, p=0.0262). (<bold>F</bold>) Change of body weight over 28 days during tamoxifen or oil injection (n = 7–8, mixed-effects model, treatment: p=0.5468). Error bars represent SEM. (<bold>G</bold>) Total change in body weight over the course of the 28-day experiment (n = 8, t<sub>13</sub> = 0.2572, p=0.8010). ns, non-significant; *, p&lt;0.05; **, p&lt;0.01; ***, p&lt;0.001; ****, p&lt;0.0001 for Sidak’s multiple comparison tests (<bold>E</bold>) following a significant effect of treatment in a two-way repeated measures ANOVA or two-tailed t-tests (<bold>B, C, and G</bold>).</p><p><supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel b.</title><p>Trabecular bone volume fraction, trabecular numbers, trabecular thickness, and trabecular separation in distal metaphysis of femurs. Each cell is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata2"><label>Figure 2—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel c.</title><p>Bone volume fraction (Ct.BV/TV), cortical thickness (Ct.Th), bone mineral density (Ct.BMD), and cortical area (Ct.Ar) in diaphysis of femurs. Each cell is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata3"><label>Figure 2—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel d.</title><p>Hourly average of movement over 3 days before and 3 weeks after tamoxifen or oil injections, measured every 5 min using an intraperitoneal telemetry probe. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata4"><label>Figure 2—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel e.</title><p>Average total movement in the light, dark, and total 24 hr periods. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata5"><label>Figure 2—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel f.</title><p>Body weight over 28 days during tamoxifen or oil injection. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data5-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig2sdata6"><label>Figure 2—source data 6.</label><caption><title>Source data for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panel g.</title><p>Total change in body weight over the course of the 28-day experiment. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig2-data6-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>Tamoxifen administration affects gene expression in all hypothalamus-POA cell types</title><p>To ask how tamoxifen affects gene expression in different cell types, we collected hypothalamus-POA (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>) after 28 daily injections of tamoxifen or vehicle and analyzed individual cells by drop-Seq (<xref ref-type="bibr" rid="bib56">Macosko et al., 2015</xref>). A total of 29,807 cells (8220 from n = 3 vehicle-treated mice, 21,587 from n = 5 tamoxifen-treated mice) clustered into nine distinct cell types, annotated based on high expression of previously characterized cell-type markers (<xref ref-type="bibr" rid="bib63">Moffitt et al., 2018</xref>; <xref ref-type="bibr" rid="bib80">Saunders et al., 2018</xref>): astrocytes, oligodendrocytes, neurons, endothelial cells, microglia, polydendrocytes, ependymal cells, mural cells, and fibroblasts (UMAP: <xref ref-type="fig" rid="fig3">Figure 3A</xref>, tSNE: <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1B</xref>, cluster defining marker expression: <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1D</xref>). Because tamoxifen modulates estrogen receptor signaling (<xref ref-type="bibr" rid="bib19">de Médina et al., 2004</xref>; <xref ref-type="bibr" rid="bib38">Jordan, 2007</xref>), we examined cell-type specific expression of three estrogen receptor transcripts: the nuclear receptors <italic>Esr1</italic> and <italic>Esr2,</italic> as well as the G-protein-coupled estrogen receptor 1 (<italic>Gper1,</italic> formerly <italic>Gpr30</italic>) (<xref ref-type="bibr" rid="bib72">Revankar et al., 2005</xref>). While neither <italic>Esr1</italic>, <italic>Esr2</italic>, nor the <italic>Esr1</italic> target gene <italic>Pgr</italic> showed strong enrichment in any particular cell type (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), <italic>Gper1</italic> transcripts were predominantly found in Mural cells (LogFC: 1.39 compared to all other cell types, adj. p&lt;1e-128). These results are in accordance with the reported <italic>Esr1</italic> expression pattern in the hypothalamus-POA (<xref ref-type="bibr" rid="bib82">Shughrue et al., 1997</xref>) and <italic>Gper1</italic> in vascular smooth muscle of the rodent brain (<xref ref-type="bibr" rid="bib35">Isensee et al., 2009</xref>). The graphical clustering methods, UMAP and tSNE, did not demonstrate clear separation between tamoxifen and vehicle treated cells (<xref ref-type="fig" rid="fig3">Figure 3C</xref>, <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1C</xref>), indicating that the effect of tamoxifen at clinically relevant doses may be modest with respect to global transcriptional signatures.</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Tamoxifen treatment induces gene expression changes in various cell types of the hypothalamus and preoptic area (hypothalamus-POA).</title><p>(<bold>A</bold>) UMAP showing clustering of the major cell types of the hypothalamus-POA based on single-cell transcriptomics. Each colored dot is a cell, with different colors representing different cell types listed to the right. (<bold>B</bold>) Dot plot showing expression of estrogen and progesterone receptors in cell types identified in (<bold>A</bold>). (<bold>C</bold>) UMAP comparing cells derived from mice receiving tamoxifen (pink) or oil injections (cyan). (<bold>D</bold>) Collapsed volcano plots showing differential gene expression, represented as log base 2 of fold change (LogFC), induced by daily tamoxifen treatment in various cell types identified. Up/down numbers refer to total number of significantly (Bonferroni adj. p&lt;0.05) up- and downregulated genes. (<bold>E</bold>) Gene set enrichment analysis (GSEA) to find tamoxifen-induced signatures of estrogen response in hypothalamus-POA cell types. (<bold>F</bold>) Most strongly enriched or depleted pathways in GSEA comparing control to tamoxifen-treated cells. All analyses were done from cells harvested from female mice injected daily with oil (n = 3) or tamoxifen (n = 5) over 28 days. (<bold>E–F</bold>) NES: Normalized enrichment score, adj. p: Benjamini-Hochberg adjusted p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>Tamoxifen treatment induces gene expression changes in various cell types of the hypothalamus and preoptic area (hypothalamus-POA).</title><p>(<bold>A</bold>) Schematic of the hypothalamus-POA dissected for scRNA-seq (Bregma +0.4 to –3 mm). (<bold>B</bold>) tSNE showing clustering of the major cell types of the hypothalamus-POA based on single-cell transcriptomics. (<bold>C</bold>) tSNE of hypothalamus-POA cells, comparing cells derived from female mice receiving tamoxifen (pink) or oil injections (cyan). (<bold>D</bold>) Violin plots showing normalized expression of cluster defining markers in all clusters. (<bold>E</bold>) Plot comparing the total number of significant (Bonferroni adj. p&lt;0.05) tamoxifen regulated genes to the number of significant tamoxifen regulated genes per thousand cells in each cluster. All analyses done from cells harvested from female mice injected daily with oil (n = 3) or tamoxifen (n = 5) over 28 days.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Among all cell types, neurons and ependymal cells were most sensitive to tamoxifen administration, as indicated by the number of significantly induced and repressed genes (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). To account for the effect of cluster size on statistical power, we also calculated the number of significant differentially expressed genes per 1 k cells in each cluster. Again, neurons and ependymal cells have the highest numbers of differentially expressed genes when expressed as total or as a fraction of the number of cells sampled (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1E</xref>), suggesting the strongest tamoxifen responsiveness. Although mural cells show significant enrichment of <italic>Gper1</italic>, tamoxifen administration was associated with relatively few significant gene expression changes in these cells (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), indicating that <italic>Gper1</italic> does not likely mediate tamoxifen-induced gene expression in the hypothalamus-POA. It is possible, however, that tamoxifen affects cellular state in a non-transcriptional manner, via <italic>Gper1</italic>. Gene set enrichment analysis (GSEA) using a gene set for estrogen response (GO:0043627) further identifies neurons and ependymal cells as markedly tamoxifen responsive: tamoxifen administration induced a significant downregulation of genes involved in estrogen response in neurons, endothelial cells, and ependymal cells (<xref ref-type="fig" rid="fig3">Figure 3E</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a</xref>). Individual gene expression changes that may be of interest can be queried at <ext-link ext-link-type="uri" xlink:href="https://correalab.shinyapps.io/tamoxifenshiny/">https://correalab.shinyapps.io/tamoxifenshiny/</ext-link>.</p><p>GSEA with a collection of 40 hallmark pathways and brain-focused gene ontology gene sets (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>) revealed that all cell types except for mural cells showed significant enrichment or depletion of genes in at least one pathway (<xref ref-type="fig" rid="fig3">Figure 3F</xref>). Significantly enriched pathways (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c</xref>) show both overlapping and distinct effects by cell type. For example, tamoxifen treatment decreased the expression of genes annotated as targets of the proto-oncogene, <italic>Myc</italic>, in astrocytes, oligodendrocytes, neurons, endothelial cells, microglia, polydendrocytes, and ependymal cells. Other cell-type specific pathways were also enriched or depleted, including establishment of the endothelial barrier in endothelial cells, neuropeptide signaling in neurons, E2F targets in astrocytes, and fatty acid metabolism in ependymal cells. Together these findings suggest that tamoxifen treatment has widespread effects on the hypothalamus-POA, altering transcriptional programs and cell function in both general and cell-type specific ways.</p></sec><sec id="s2-4"><title>Tamoxifen treatment causes gene expression changes in neuronal subtypes of the hypothalamus-POA</title><p>Given the transcriptional effects of tamoxifen treatment observed in neurons and the heterogeneity of estrogen-sensitive neurons within the hypothalamus-POA, we next examined the effect of tamoxifen treatment within individual neuronal clusters. Neuronal sub-clustering resulted in 25 apparent neuronal subtypes (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). The majority of clusters were marked by expression of genes previously demonstrated to delineate neuronal types within the hypothalamus (<xref ref-type="fig" rid="fig4">Figure 4B</xref>; <xref ref-type="bibr" rid="bib12">Chen et al., 2017</xref>; <xref ref-type="bibr" rid="bib74">Romanov et al., 2017</xref>; <xref ref-type="bibr" rid="bib39">Kim et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">van Veen et al., 2020</xref>). Markers of neuronal subtypes include neuropeptides, transcription factors, and cellular signaling messengers. <italic>Esr1</italic> expression was observed in various neuronal subclusters (<xref ref-type="fig" rid="fig4">Figure 4B</xref>), but was significantly enriched in wild-type neurons expressing the neuropeptide precursor, <italic>Tac2</italic> (log<sub>2</sub>FC = 1.52, adj. p=7.1e-36) and neurons expressing the neuropeptide precursor <italic>Gal</italic> (log<sub>2</sub>FC = 0.50, adj. p=1.6e-30) compared to all other neuronal subclusters. The ERα target gene <italic>Pgr</italic> also was significantly enriched in wild-type neurons expressing <italic>Tac2</italic> (log<sub>2</sub>FC = 0.49, adj. p=2.3e-4) compared to all other neuronal subclusters. GSEA demonstrates that overall, tamoxifen administration is associated with a significant down-regulation of genes involved in neuropeptide signaling, a critical aspect of neuronal function, as well as the two principal components fueling the sizeable energy demands of neuronal metabolism: oxidative phosphorylation and glycolysis (<xref ref-type="bibr" rid="bib99">Yellen, 2018</xref>; <xref ref-type="fig" rid="fig4">Figure 4C</xref>). Notably, it has previously been shown that estrogens can directly regulate these metabolic pathways in the brain (<xref ref-type="bibr" rid="bib6">Brinton, 2008</xref>; <xref ref-type="bibr" rid="bib7">Brinton, 2009</xref>). When divided into subtypes, few statistically significant gene expression changes caused by tamoxifen were observed, likely due to loss of statistical power resulting from relatively few cells in each individual cluster (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1A</xref>). To gain a preliminary view at the effect of tamoxifen on individual neuronal subtypes, we performed GSEA on all clusters; 14 of 25 neuronal types showed enrichment of at least one pathway (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1d</xref>). Neurons marked by expression of <italic>Tac2</italic> showed significant enrichment or depletion of the most pathways (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). Interestingly, examining individual pathways shows differential responses by neuronal subtype. For example, genes involved in oxidative phosphorylation appear downregulated by tamoxifen in neurons expressing <italic>Foxb1</italic>, but the same gene set is upregulated in neurons expressing <italic>Tac2</italic> (<xref ref-type="fig" rid="fig4s1">Figure 4—figure supplement 1B</xref>). These cell-type specific effects highlight the additional insights that can be revealed by scRNA-seq compared to overall averages determined by bulk tissue sequencing. Additionally, these results are compatible with the previous findings that tamoxifen can have different effects in different regions of the brain (<xref ref-type="bibr" rid="bib94">Wilson et al., 2003</xref>; <xref ref-type="bibr" rid="bib11">Chen et al., 2014</xref>; <xref ref-type="bibr" rid="bib28">Gibbs et al., 2014</xref>; <xref ref-type="bibr" rid="bib1">Aquino et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Sá et al., 2016</xref>) and consistent with cell-type specific effects of tamoxifen within neurons of the hypothalamus-POA.</p><fig-group><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Tamoxifen-induced gene expression changes in neurons of the hypothalamus and preoptic area (hypothalamus-POA).</title><p>(<bold>A</bold>) UMAP showing clustering of the neuronal subtypes of the hypothalamus-POA based on single-cell transcriptomics, overlayed with identity named for top expressed cluster defining marker gene. (<bold>B</bold>) Dot plot showing expression of neuronal cluster defining markers, <italic>Esr1, Esr2, Gper1, and Pgr</italic>. (<bold>C</bold>) Volcano plots of tamoxifen-induced or repressed differentially expressed genes (DEGs) overlayed with gene sets (GS) involved in neuropeptide signaling, oxidative phosphorylation, or glycolysis. Analyses done from wild-type female mice injected daily with oil (n = 3) or tamoxifen (n = 5) over 28 days. NES: Normalized enrichment score, GSEA adj. p: Benjamini-Hochberg adjusted p-value, DEG adj. p: Bonferroni adjusted p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig4-v1.tif"/></fig><fig id="fig4s1" position="float" specific-use="child-fig"><label>Figure 4—figure supplement 1.</label><caption><title>Tamoxifen-induced gene expression changes in hypothalamus and preoptic area (hypothalamus-POA) neurons.</title><p>(<bold>A</bold>) Collapsed volcano plot of differences in gene expression associated with tamoxifen treatment in the various neuronal subtypes of wild-type female mice. adj. p: Bonferroni adjusted p-value. (<bold>B</bold>) Gene set enrichment analysis (GSEA) pathways significantly (Benjamini-Hochberg adjusted p&lt;0.05) upregulated or downregulated by tamoxifen in individul neuronal subclusters. NES: Normalized enrichment score.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig4-figsupp1-v1.tif"/></fig></fig-group></sec><sec id="s2-5"><title><italic>Esr1</italic> conditional knockout ablates gene expression responses to tamoxifen</title><p>As <italic>Esr1</italic> is a known target of tamoxifen that is expressed in the hypothalamus-POA (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), we sought to determine the impact of <italic>Esr1</italic> knockout on gene expression responses to tamoxifen administration. The NK2 homeobox transcription factor, <italic>Nkx2-1</italic>, is highly enriched in the medial basal hypothalamus and <italic>Esr1<sup>F/F</sup></italic>; <italic>Nkx2-1<sup>Cre</sup></italic> (<italic>Esr1</italic> cKO) mice display a selective loss of ERα immunoreactivity in the hypothalamus-POA (<xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>; <xref ref-type="bibr" rid="bib33">Herber et al., 2019</xref>). Here, single-cell RNA expression analysis was unable to detect a significant decrease of <italic>Esr1</italic> transcripts in cells of the hypothalamus-POA in <italic>Esr1</italic> cKO mice (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), though both <italic>Nkx2-1</italic> and <italic>Esr1</italic> transcripts are present in various cell types of the hypothalamus-POA (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1B</xref>), suggesting that the Cre and floxed alleles might be co-expressed within certain cell types. Indeed, 104 cells were found to express both <italic>Esr1</italic> and <italic>Nkx2-1</italic>. Of these 104, 79 were neurons, 19 were ependymal cells, 3 were astrocytes, 2 were microglia, and 1 was an endothelial cell. Most importantly, ERα immunoreactivity was clearly ablated in several areas of the hypothalamus-POA of <italic>Esr1</italic> cKO mice, including the medial preoptic area (MPA), ventrolateral subdivision of the ventromedial nucleus of the hypothalamus (VMHvl), and arcuate nucleus of the hypothalamus (ARC) (<xref ref-type="fig" rid="fig5">Figure 5A</xref>). Notably, the MPA, ARC, and VMHvl show highly enriched ERα expression in wild-type mice (<xref ref-type="bibr" rid="bib60">Merchenthaler et al., 2004</xref>), and these regions mediate the effects of estrogens on body temperature (<xref ref-type="bibr" rid="bib97">Xu et al., 2011</xref>; <xref ref-type="bibr" rid="bib59">Mauvais-Jarvis et al., 2013</xref>; <xref ref-type="bibr" rid="bib57">Martínez de Morentin et al., 2014</xref>), physical activity (<xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>; <xref ref-type="bibr" rid="bib44">Krause et al., 2019</xref>; <xref ref-type="bibr" rid="bib89">van Veen et al., 2020</xref>), and bone regulation (<xref ref-type="bibr" rid="bib23">Farman et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Herber et al., 2019</xref>).</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title><italic>Esr1</italic> conditional knockout reverses hypothalamus and preoptic area (hypothalamus-POA) responses to tamoxifen.</title><p>(<bold>A</bold>) Immunoreactive staining of estrogen receptor alpha (ERα) in the medial preoptic area (MPA), ventromedial nucleus of the hypothalamus (VMH), and the arcuate nucleus of the hypothalamus (ARC) of ERα knockout and wild-type female mice. Scale bar: 200 um. (<bold>B</bold>) Differentially expressed genes (DEGs) induced by daily tamoxifen treatment in cell types of the <italic>Esr1<sup>f/f</sup>;Nkx2-1<sup>Cre</sup></italic> (<italic>Esr1</italic> cKO) hypothalamus-POA. Up/down numbers refer to total number of significantly (Bonferroni adj. p&lt;0.05) up- and downregulated genes. (<bold>C</bold>) Table of correlations showing how tamoxifen-induced gene expression changes in wild-type cells correlate with tamoxifen-induced gene expression changes in <italic>Esr1</italic> cKO cells. Rho: Spearman correlation coefficient, adj. p: Benjamini-Hochberg adjusted p-value. (<bold>D</bold>) Gene-by-gene comparison of how tamoxifen treatment affects expression in wild-type and <italic>Esr1</italic> cKO neurons and ependymal cells. Named genes are a subset of genes discordantly regulated by tamoxifen in wild-type and <italic>Esr1</italic> cKO cells. A complete list of genes shown here is in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1i</xref>. (<bold>E</bold>) Volcano plots of all tamoxifen-induced or repressed DEGs (black) overlayed with gene sets (purple) involved in oxidative phosphorylation or glycolysis. NES: Normalized enrichment score, gene set enrichment analysis (GSEA) adj. p: Benjamini-Hochberg adjusted p-value, DEG adj. p: Bonferroni adjusted p-value. (<bold>B–E</bold>) Data from n = 4 oil treated <italic>Esr1</italic> cKO and n = 4 tamoxifen-treated <italic>Esr1</italic> cKO, n = 3 oil treated wild-type and n = 5 tamoxifen-treated wild-type mice.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig5-v1.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Cell cluster analyses across all four treatment groups.</title><p>(<bold>A</bold>) Collapsed volcano plot showing the average fold change (avg_logFC) in <italic>Esr1</italic> transcript expression in <italic>Esr1</italic> cKO vs. wild-type mice. (<bold>B</bold>) Dotplot showing expression of <italic>Esr1</italic> and <italic>Nkx2-1</italic> in cell types of the hypothalamus and preoptic area (hypothalamus-POA). (<bold>C</bold>) UMAP of all hypothalamus-POA derived cell types showing individual cells (dots) from the four treatment groups. (<bold>D</bold>) UMAP of hypothalamus-POA derived neuronal types showing individual neurons (dots) from the four treatment groups. (<bold>E</bold>) Proportion of each cell type recovered across the four treatment groups. Three-way ANOVA (main effects: cluster x genotype x treatment) shows an effect of cluster (F<sub>8,108</sub>=91.33, p&lt;0.0001) and the cluster x genotype interaction (F<sub>8,108</sub>=4.775, p&lt;0.0001). Two-way ANOVA (cluster x genotype collapsed across treatments) shows an effect of cluster (F<sub>8,112</sub>=86.87, p&lt;0.0001) and the cluster x genotype interaction (F<sub>8,112</sub>=4.218, p=0.0002). Sidak’s multiple comparisons tests reveal effects of genotype on the proportion of astrocytes (t<sub>126</sub> = 5.138) and oligodendrocytes (t<sub>126</sub> = 2.896). All other main effects, interactions, and multiple comparisons p&gt;0.05.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig5-figsupp1-v1.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Comparison of gene expression changes induced by tamoxifen in wild-type and <italic>Esr1</italic> cKO mice.</title><p>(<bold>A</bold>) Key to comparison of genes induced by tamoxifen in wild-type compared to how they are regulated by tamoxifen in <italic>Esr1</italic> cKO animals. (<bold>B</bold>) Gene-by-gene comparisons of how tamoxifen treatment affects expression in wild-type and <italic>Esr1</italic> cKO cells. Each dot is a gene. Only genes significantly up- or downregulated by tamoxifen in wild-type mice are shown. (<bold>C</bold>) Gene set enrichment analysis (GSEA) NES showing tamoxifen regulation of estrogen responsive genes in wild-type and <italic>Esr1</italic> cKO hypothalamus and preoptic area (hypothalamus-POA) cell types. (<bold>D</bold>) GSEA NES showing tamoxifen regulation of estrogen responsive genes in wild-type and <italic>Esr1</italic> cKO neuronal subtypes. NES: Normalized enrichment score, adj. p: Benjamini-Hochberg adjusted p-value.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig5-figsupp2-v1.tif"/></fig></fig-group><p>To test the effect of tamoxifen administration on gene expression in mice lacking ERα in the hypothalamus-POA, <italic>Esr1</italic> cKO mice received the same daily tamoxifen or vehicle injection regimen concurrently with wild-type mice (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). UMAP Clustering of all four treatment conditions, vehicle or tamoxifen in wild-type or <italic>Esr1</italic> cKO animals, did not reveal clear separation in global transcriptional signature between any treatment group when considering all cell types (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1C</xref>) or re-clustered neuronal subtypes (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1D</xref>). <italic>Esr1</italic> cKO animals showed proportionally fewer astrocytes and more oligodendrocytes than wild-type animals (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>), though all other cell types were recovered at similar proportions. Tamoxifen treatment was not associated with any significant differences in recovered cell type proportions (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1E</xref>).</p><p>Interestingly, tamoxifen treatment led to significant transcriptional changes in the hypothalamus-POA of <italic>Esr1</italic> cKO mice (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). Similar to wild-type, <italic>Esr1</italic> cKO neurons and ependymal cells were the cell types most sensitive to tamoxifen administration compared to all other cell types, as indicated by the number of significantly induced and repressed genes (<xref ref-type="fig" rid="fig5">Figure 5B</xref>). To look closer at the specific effects of tamoxifen on gene regulation, and to ask if they depend on expression of <italic>Esr1</italic>, we examined those gene expression changes that were significant in wild-type cells and asked how those same genes were regulated in equivalent <italic>Esr1</italic> cKO cells. For this gene-by-gene comparison, there was a strong negative Spearman correlation observed in most cell types (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). This negative correlation implies that the majority of significant tamoxifen-induced gene expression changes that were observed in cell types of wild-type female mice were ablated or regulated in the opposite direction in <italic>Esr1</italic> cKO animals.</p><p>In wild-type neurons, the majority of tamoxifen-regulated genes were repressed by tamoxifen (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In <italic>Esr1</italic> cKO neurons, most of these same genes are no longer repressed by tamoxifen (<xref ref-type="fig" rid="fig5">Figure 5D</xref>, Key: <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2A</xref>). In wild-type ependymal cells, the majority of regulated genes were induced by tamoxifen (<xref ref-type="fig" rid="fig3">Figure 3D</xref>) and the majority of these same genes were suppressed by tamoxifen in <italic>Esr1</italic> cKO ependymocytes (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Despite identifying fewer differentially expressed genes, the other cell types showed similar trends (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2B</xref>). These data suggest that tamoxifen has generally suppressive effects on neuronal transcription and generally inductive effects on ependymal cells; further, it suggests that these effects are largely dependent on expression of <italic>Esr1</italic>.</p><p>To determine if the overall opposite effects of tamoxifen in <italic>Esr1</italic> cKO compared to wild-type animals was associated with corresponding changes in functional pathways, we performed GSEA with all cell-type clusters as before. GSEA for estrogen responsive genes in all cell types showed that tamoxifen downregulated estrogen responsive genes in multiple cell types of the wild-type hypothalamus-POA but did not significantly affect the same gene set in cells of the <italic>Esr1</italic> cKO hypothalamus-POA, even when using a permissive cutoff for significance (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2C</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1a and 1f</xref>). GSEA in individual wild-type neuronal subclusters showed that tamoxifen downregulated estrogen responsive genes in various neuronal subtypes. Tamoxifen also downregulated estrogen responsive genes in some <italic>Esr1</italic> cKO neuronal subclusters (<xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2D</xref>, <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1g and 1h</xref>), but this effect was attenuated compared to wild-type. Many other functional pathways were altered in opposite directions in <italic>Esr1</italic> cKO cells compared to wild-type cells following tamoxifen treatment (complete results: <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c and 1e</xref>). This pattern included <italic>Myc</italic> targets in endothelial cells, ependymal cells, neurons, oligodendrocytes, and polydendrocytes. Importantly, we also found a significant change of metabolic gene expression in neurons, as both oxidative phosphorylation and glycolysis were upregulated by tamoxifen in <italic>Esr1</italic> cKO neurons (<xref ref-type="fig" rid="fig5">Figure 5E</xref>) but downregulated in wild-type neurons (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). This trend of opposing effects of tamoxifen was not universal, as <italic>Tnf-a</italic> signaling was significantly downregulated by tamoxifen in both <italic>Esr1</italic> cKO and wild-type endothelial cells. Finally, many pathways, including <italic>mTorc1</italic> signaling in astrocytes, establishment of the endothelial barrier in endothelial cells, and neuropeptide signaling in neurons, were significantly affected by tamoxifen in wild-type cells, but not affected in their <italic>Esr1</italic> cKO counterparts (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1c and 1e</xref>). Together these data demonstrate that the majority of tamoxifen-induced changes in gene expression in the hypothalamus-POA are dependent upon expression of ERα in the <italic>Nkx2-1</italic> lineage. This includes many functional pathways (e.g., neuronal activity and estrogen responsive genes) in many cell types and neuronal subtypes.</p></sec><sec id="s2-6"><title>The homeostatic effects of tamoxifen are dependent on ERα</title><p>Given the known roles of ERα in mediating many aspects of physiology, as well as the effect of ERα conditional knockout on the transcriptomic effects of tamoxifen, we asked if loss of ERα would also affect physiological responses to tamoxifen in mice. We therefore measured body temperature, movement, and bone density in <italic>Esr1</italic> cKO mice treated equivalently and concurrently with wild-type animals (<xref ref-type="fig" rid="fig1">Figure 1A</xref>). Interestingly, tamoxifen injection was not associated with any difference in core body temperature in <italic>Esr1</italic> cKO mice compared to vehicle-treated controls (treatment: F(1, 14)=0.1395, p=0.7144) (<xref ref-type="fig" rid="fig6">Figure 6A–B</xref>). Specifically, we did not detect any significant differences in heat dissipation or production when comparing <italic>Esr1</italic> cKO mice treated with tamoxifen vs. vehicle, as indicated by HLI (treatment: F(1, 13)=3.109, p=0.1013) (<xref ref-type="fig" rid="fig6">Figure 6C–D</xref>) and BAT temperature (t = 0.2640, df = 4, p=0.8048) (<xref ref-type="fig" rid="fig6">Figure 6E–F</xref>). In contrast to wild-type mice, there was no significant difference in movement between tamoxifen and vehicle treatment in <italic>Esr1</italic> cKO mice (treatment: F(1, 14)=2.638, p=0.1266) (<xref ref-type="fig" rid="fig6">Figure 6G–H</xref>).</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The homeostatic effects of tamoxifen are dependent on estrogen receptor alpha (ERα) in the hypothalamus and preoptic area (hypothalamus-POA).</title><p>(<bold>A</bold>) Hourly average of core body temperature in <italic>Esr1</italic> cKO female mice over 2 days before and 3 weeks after injections (dotted line). (<bold>B</bold>) Average core body temperature from mice shown in panel (<bold>A</bold>) highlighting per animal averages in light (7:00 to 19:00), dark (19:00 to 7:00), and total 24 hr periods (n = 8, treatment: F<sub>1,14</sub>=1.395, p=0.7144). (<bold>C</bold>) Heat loss index (HLI) calculated from continuous measurements of core and tail temperature. (<bold>D</bold>) Average HLI from mice shown in panel (<bold>C</bold>) (n = 7–8, treatment: F<sub>1,13</sub>=3.109, p=0.1013). (<bold>E</bold>) Thermographic images of interscapular skin above brown adipose tissues (BAT) depots in <italic>Esr1</italic> cKO female mice injected with either oil or tamoxifen. (<bold>F</bold>) Quantification of temperature of skin above intrascapular BAT depots (n = 3, t<sub>4</sub> = 0.264, p=0.8048). (<bold>G</bold>) Hourly average of movement over 2 days before and after injections (dotted line). (<bold>H</bold>) Average movement from mice shown in panel (<bold>H</bold>) (n = 8, treatment: F<sub>1,14</sub>=2.638, p=0.1266). (<bold>I</bold>) Representative micro-computed tomography (microCT) images showing bone density of the distal metaphysis and midshaft diaphysis of femurs from tamoxifen or oil treated <italic>Esr1</italic> cKO female mice. (<bold>J</bold>) Trabecular bone volume fraction (BV/TV, t<sub>10</sub> = 0.8340, p=0.4237), trabecular numbers (Tb.N, t<sub>10</sub> = 3.349, p=0.0074), trabecular thickness (Tb.Th, t<sub>10</sub> = 0.2668, p=0.7951), and trabecular separation (Tb.Sp, t<sub>10</sub> = 1.924, p=0.0832) in distal metaphysis of femurs (n = 6). (<bold>K</bold>) Bone volume fraction (Ct.BV/TV, t<sub>10</sub> = 0.5963, p=0.5643) and cortical thickness (Ct.Th, t<sub>10</sub> = 0.9720, p=0.354) in diaphysis of femurs (n = 6). Line shading and error bars represent standard error of the mean (SEM). ns, non-significant; **, p&lt;0.01 for Sidak's multiple comparisons test (<bold>B, D, and H</bold>) or two-tailed t-test (<bold>F, J, and K</bold>).</p><p><supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel a.</title><p>Hourly average of core body temperature in <italic>Esr1</italic> cKO female mice over 2 days before and 3 weeks after injections. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data1-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata2"><label>Figure 6—source data 2.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel b.</title><p>Average core body temperature from <italic>Esr1</italic> cKO mice in light, dark, and total 24 hr periods. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data2-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata3"><label>Figure 6—source data 3.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel c.</title><p>Hourly average of heat loss index (HLI) calculated from continuous measurements of core and tail temperature in <italic>Esr1</italic> cKO female mice treated with oil or Tmx. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data3-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata4"><label>Figure 6—source data 4.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel d.</title><p>Average heat loss index (HLI) in the light, dark, and total 24 hr periods for <italic>Esr1</italic> cKO female mice treated with oil or Tmx. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data4-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata5"><label>Figure 6—source data 5.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel f.</title><p>Quantification of temperature of skin above intrascapular brown adipose tissue (BAT) depots in <italic>Esr1</italic> cKO female mice treated with oil or Tmx. Each cell is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data5-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata6"><label>Figure 6—source data 6.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel g.</title><p>Hourly average of movement over 2 days before and 3 weeks after injections of oil or tamoxifen in <italic>Esr1</italic> cKO female mice. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data6-v1.xlsx"/></supplementary-material></p><p><supplementary-material id="fig6sdata7"><label>Figure 6—source data 7.</label><caption><title>Source data for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panel h.</title><p>Average movement in light, dark, and 24 hr periods over 2 days before and 3 weeks after injections of oil or tamoxifen in <italic>Esr1</italic> cKO female mice. Each column is an independent mouse.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-fig6-data7-v1.xlsx"/></supplementary-material></p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-fig6-v1.tif"/></fig><p>Knockout of ERα in the hypothalamus-POA largely blocked the effect of tamoxifen on bone physiology as well. No difference was observed in bone volume fraction (t = 0.8340, df = 10, p=0.4237), thickness (t = 0.2668, df = 10, p=0.7951), or separation of trabeculae (t = 1.924, df = 10, p=0.0832) when comparing tamoxifen to vehicle-treated animals. In contrast to wild-type mice, we observed a tamoxifen-induced reduction in trabecular number (t = 3.349, df = 10, p=0.0074) (<xref ref-type="fig" rid="fig6">Figure 6I–J</xref>). There was no significant difference in bone volume ratio (t = 0.5963, df = 10, p=0.5643) or cortical thickness (t = 0.9720, df = 10, p=0.3540) in the cortical bones of mice treated with tamoxifen compared to mice treated with vehicle (<xref ref-type="fig" rid="fig6">Figure 6I and K</xref>). Taken together, these results suggest that the dysregulation of core temperature, reduced movement, and changed bone physiology associated with tamoxifen treatment in wild-type mice are largely dependent upon the expression of ERα in the <italic>Nkx2-1</italic> lineage.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Tamoxifen is a selective estrogen receptor modulator that exerts antiproliferative effects on cancer cells through ERα (<xref ref-type="bibr" rid="bib17">Davies et al., 2011</xref>), but can exert agonistic or antagonistic effects on the different estrogen receptors depending on cell type and context (<xref ref-type="bibr" rid="bib93">Watanabe et al., 1997</xref>; <xref ref-type="bibr" rid="bib62">Mo et al., 2013</xref>). The hypothalamus-POA is rich in estrogen receptor expression, making it a prime candidate as a tamoxifen target (<xref ref-type="bibr" rid="bib60">Merchenthaler et al., 2004</xref>; <xref ref-type="bibr" rid="bib30">Gofflot et al., 2007</xref>; <xref ref-type="bibr" rid="bib58">Matsuda et al., 2013</xref>; <xref ref-type="bibr" rid="bib78">Saito et al., 2016</xref>). Here, we take the first steps to define the cell types and cellular mechanisms that mediate some of the undesirable side effects experienced by people undergoing tamoxifen therapy. We demonstrate the utility of mice as a good model to study many of tamoxifen’s physiological effects; tamoxifen administration in mice increases heat dissipation, decreases movement, and increases bone density. These effects are similar to those experienced by people receiving tamoxifen therapy, who experience hot flashes, lethargy, and changes in bone density, among other symptoms (<xref ref-type="bibr" rid="bib54">Love et al., 1991</xref>; <xref ref-type="bibr" rid="bib70">Powles et al., 1996</xref>; <xref ref-type="bibr" rid="bib25">Fisher et al., 1998</xref>; <xref ref-type="bibr" rid="bib53">Loprinzi et al., 2000</xref>; <xref ref-type="bibr" rid="bib32">Haghighat et al., 2003</xref>; <xref ref-type="bibr" rid="bib34">Howell et al., 2005</xref>; <xref ref-type="bibr" rid="bib41">Kligman and Younus, 2010</xref>; <xref ref-type="bibr" rid="bib26">Francis et al., 2015</xref>).</p><p>Using single-cell RNA sequencing, we find that tamoxifen alters transcriptomes in the hypothalamus-POA, consistent with the hypothesis that tamoxifen treatment alters central nervous system function (<xref ref-type="bibr" rid="bib21">Eberling et al., 2004</xref>; <xref ref-type="bibr" rid="bib28">Gibbs et al., 2014</xref>; <xref ref-type="bibr" rid="bib20">Denk et al., 2015</xref>). Indeed, tamoxifen and its metabolites are detectable and up to 46-fold higher in the brain than in serum of breast cancer patients (<xref ref-type="bibr" rid="bib48">Lien et al., 1991</xref>). We report that tamoxifen treatment affects gene expression in many cell types but most strongly in neurons and ependymal cells. These findings are consistent with previous reports of tamoxifen-induced gene expression changes within neurons (<xref ref-type="bibr" rid="bib52">López et al., 2006</xref>; <xref ref-type="bibr" rid="bib1">Aquino et al., 2016</xref>; <xref ref-type="bibr" rid="bib77">Sá et al., 2016</xref>), and tamoxifen-induced stress in neurons and ependymal cells (<xref ref-type="bibr" rid="bib20">Denk et al., 2015</xref>). Although much higher doses, such as those used to activate tamoxifen-inducible mouse models (25–100 mg/kg), can inhibit neural progenitor cell proliferation during cortical patterning or induce adipogenesis and prolonged genetic effects (<xref ref-type="bibr" rid="bib98">Ye et al., 2015</xref>; <xref ref-type="bibr" rid="bib47">Lee et al., 2020</xref>), we do not detect any changes in the proportion of different cell types after 28 days of treatment with a clinically relevant dose (0.1 mg/kg) of tamoxifen.</p><p>Notably, conditional knockout of the <italic>Esr1</italic> gene encoding ERα did not render the brain insensitive to tamoxifen. Instead it ablated or reversed the direction of a significant number of the tamoxifen-induced gene expression changes that were observed in the wild-type hypothalamus-POA. Importantly, this reversal encompassed many functional pathways including those controlling metabolism and neuropeptide signaling in neurons. The many transcriptional changes induced by tamoxifen in <italic>Esr1</italic> cKO mice might be attributed to tamoxifen’s effects on the other estrogen receptors or effects mediated by cells outside of the <italic>Nkx2-1</italic> lineage. Indeed, studies of breast cancer resistance suggest many other signaling pathways, for example, Pgr, androgen receptor, and GPER may be involved in the actions of tamoxifen on transcription (<xref ref-type="bibr" rid="bib62">Mo et al., 2013</xref>; <xref ref-type="bibr" rid="bib76">Rondón-Lagos et al., 2016</xref>). Pgr expression in the hypothalamus is regulated by both endogenous estrogens and tamoxifen (<xref ref-type="bibr" rid="bib77">Sá et al., 2016</xref>) and we find that <italic>Pgr</italic> is most abundant in neurons. Although more enriched in mural cells, GPER has been shown to increase acetylcholine release in neurons of the hippocampus (<xref ref-type="bibr" rid="bib28">Gibbs et al., 2014</xref>). Nevertheless, conditional knockout of ERα in the hypothalamus-POA blocked the majority of the physiological changes observed in wild-type mice by tamoxifen, indicating a pivotal role of ERα in mediating the homeostatic effects of tamoxifen. Together, these data indicate an indispensable role for ERα in the molecular and physiological response to tamoxifen treatment in mice. In addition, our data indicate that tamoxifen exerts potent effects on gene expression in a variety of neuronal subtypes, as well as in ependymal cells. It is very likely that the pleiotropic physiological effects of tamoxifen involve various estrogen responsive cells and brain regions. Determining which regions of the hypothalamus-POA respond directly to tamoxifen and which nuclei mediate the various effects of tamoxifen will require careful region and cell-type specific <italic>Esr1</italic> deletion studies.</p><p>Hot flashes are one of the most common complaints by people undergoing tamoxifen therapy or transitioning to menopause (<xref ref-type="bibr" rid="bib85">Stearns et al., 2002</xref>; <xref ref-type="bibr" rid="bib41">Kligman and Younus, 2010</xref>). Hot flashes are characterized by frequent, sudden increases of heat dissipation from the skin, often accompanied with sweats and transient decreases in core body temperature (<xref ref-type="bibr" rid="bib85">Stearns et al., 2002</xref>). The precise mechanisms behind this change in thermoregulatory responses are unknown; however, several studies have suggested that a disruption in central sex hormone signaling is involved. The hypothalamus-POA is a central site for both sex hormone action and body temperature regulation and appears to play a role in the etiology of hot flashes. Specifically, activating neurons in the ARC that co-express kisspeptin, neurokinin B, and dynorphin (KNDy neurons, which also express ERα) or manipulating their downstream neurokinin B signaling in the POA induces hot flash-like symptoms in rodents and humans (<xref ref-type="bibr" rid="bib16">Dacks et al., 2011</xref>; <xref ref-type="bibr" rid="bib36">Jayasena et al., 2015</xref>; <xref ref-type="bibr" rid="bib67">Padilla et al., 2018</xref>). We detected the highest <italic>Esr1</italic> expression levels in neurons marked by expression of the neurokinin B precursor gene, <italic>Tac2</italic>, suggesting that tamoxifen may interact with neurokinin B signaling through ERα in the ARC or the POA. Indeed, <italic>Esr1</italic> cKO mice which showed loss of ERα in the ARC and POA (<xref ref-type="fig" rid="fig5">Figure 5A</xref>) did not exhibit tamoxifen-induced tail and core temperature changes. Together, these data suggest the hypothesis that tamoxifen induces hot flashes via estrogen-sensitive neural circuits involved in thermoregulation. However, it is important to acknowledge that the sustained increase in tail skin temperature observed here and in other animal models (<xref ref-type="bibr" rid="bib42">Kobayashi et al., 2000</xref>; <xref ref-type="bibr" rid="bib67">Padilla et al., 2018</xref>) does not fully reflect the episodic nature of hot flashes in humans. Additionally, there is evidence that other ERs can contribute to estrogen’s effects on thermoregulation. For example, treating ovariectomized rats with selective ligands for ERβ can mimic the effects of estradiol treatment on tail skin temperature (<xref ref-type="bibr" rid="bib66">Opas et al., 2009</xref>). Similarly, a Gq-coupled estrogen receptor ligand (STX) is able to decrease core body temperature similar to E2 in guinea pigs after ovariectomy (<xref ref-type="bibr" rid="bib73">Roepke et al., 2010</xref>). Although the effects of estrogens on thermoregulation are probably multifaceted and complex, it is clear that ablating ERα is sufficient to abrogate the effects of tamoxifen on core body temperature and tail skin temperature in mice.</p><p>Animal studies indicate that estrogen signaling promotes movement (<xref ref-type="bibr" rid="bib65">Ogawa et al., 2003</xref>; <xref ref-type="bibr" rid="bib49">Lightfoot, 2008</xref>), although in humans, estrogen related activity changes remain controversial (see review <xref ref-type="bibr" rid="bib5">Bowen et al., 2011</xref>). In female breast cancer patients, there is a significant association between ongoing tamoxifen usage and symptoms of fatigue (<xref ref-type="bibr" rid="bib32">Haghighat et al., 2003</xref>). Our results demonstrate that ERα in the hypothalamus-POA mediates a suppressive effect of tamoxifen on movement. This is consistent with the results that ERα signaling in the hypothalamus-POA regulates physical activity in mice (<xref ref-type="bibr" rid="bib65">Ogawa et al., 2003</xref>; <xref ref-type="bibr" rid="bib64">Musatov et al., 2007</xref>; <xref ref-type="bibr" rid="bib97">Xu et al., 2011</xref>; <xref ref-type="bibr" rid="bib79">Sano et al., 2013</xref>; <xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>; <xref ref-type="bibr" rid="bib89">van Veen et al., 2020</xref>). Specifically, activation of ERα neurons in the <italic>Nkx2-1</italic> lineage promotes movement (<xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>) and loss of ERα in the VMH reduces physical activity in mice (<xref ref-type="bibr" rid="bib64">Musatov et al., 2007</xref>; <xref ref-type="bibr" rid="bib14">Correa et al., 2015</xref>). In addition, the POA is rich in ERα expression and has been shown to be responsible for estrogen induced running wheel activity (<xref ref-type="bibr" rid="bib40">King, 1979</xref>; <xref ref-type="bibr" rid="bib22">Fahrbach et al., 1985</xref>; <xref ref-type="bibr" rid="bib87">Takeo and Sakuma, 1995</xref>). Although ERβ also is expressed in the hypothalamus-POA, physical activity is primarily regulated by ERα signaling in mice (<xref ref-type="bibr" rid="bib65">Ogawa et al., 2003</xref>). Therefore, tamoxifen may act as an ERα antagonist in those estrogen-sensitive regions to suppress physical activity in mice.</p><p>Similar to endogenous estrogens, tamoxifen has profound effects on bone remodeling. Human studies have demonstrated that tamoxifen is protective against bone mineral density loss after menopause but induces bone loss before menopause (<xref ref-type="bibr" rid="bib55">Love et al., 1992</xref>; <xref ref-type="bibr" rid="bib45">Kristensen et al., 1994</xref>; <xref ref-type="bibr" rid="bib70">Powles et al., 1996</xref>; <xref ref-type="bibr" rid="bib90">Vehmanen et al., 2006</xref>). In contrast, animal studies have generally shown protective effects of tamoxifen on bone, regardless of ovarian function (<xref ref-type="bibr" rid="bib88">Turner et al., 1988</xref>; <xref ref-type="bibr" rid="bib69">Perry et al., 2005</xref>; <xref ref-type="bibr" rid="bib84">Starnes et al., 2007</xref>). Whether these discrepancies are due to fundamental differences between rodent and human bone biology remains to be determined. We found that tamoxifen greatly increased bone mass in wild-type mice, displaying an estrogen-like protective effect. Although this study did not evaluate bone formation and resorption respectively, a number of animal studies have indicated that tamoxifen can stimulate bone formation (<xref ref-type="bibr" rid="bib69">Perry et al., 2005</xref>) and also suppress bone resorption (<xref ref-type="bibr" rid="bib88">Turner et al., 1988</xref>; <xref ref-type="bibr" rid="bib71">Quaedackers et al., 2001</xref>), resulting in a net bone accruement. We did not detect an effect of tamoxifen on bone volume in <italic>Esr1</italic> cKO mice and observed opposite changes on trabecular bone number compared to that in wild-type mice. These results suggest that at least some of the effects of tamoxifen on bone are mediated by ERα signaling within the <italic>Nkx2-1</italic> lineage. ERα signaling outside of the <italic>Nkx2-1</italic> lineage or other estrogen receptor subtypes may also contribute to the effects observed in wild-type mice (<xref ref-type="bibr" rid="bib95">Windahl et al., 2002</xref>). Indeed, E2 replacement after ovariectomy can increase cortical bone dimensions in ERα and ERβ double KO mice (<xref ref-type="bibr" rid="bib50">Lindberg et al., 2002</xref>) and a Gq-coupled estrogen receptor ligand is able to increase bone density in guinea pigs after ovariectomy (<xref ref-type="bibr" rid="bib73">Roepke et al., 2010</xref>). However, depletion of ERα in the medial basal hypothalamus or specifically within the KNDy neurons results in an impressive increase in bone mass (<xref ref-type="bibr" rid="bib23">Farman et al., 2016</xref>; <xref ref-type="bibr" rid="bib33">Herber et al., 2019</xref>), suggesting that the strongest effects of estrogens on bone may be mediated by hypothalamic ERα. The potent effect of hypothalamic ERα on bone is consistent with our finding that conditional ERα ablation in the hypothalamus-POA can abrogate the effects of tamoxifen on bone volume. However, it is possible that we were unable to detect more subtle effects of tamoxifen on bone in <italic>Esr1</italic> cKO mice, as these could be masked by the dramatic alteration in bone metabolism observed in <italic>Esr1</italic> cKO mice.</p><p>Although the <italic>Nkx2-1</italic> lineage includes cells in the thyroid, pituitary, and lung, <italic>Esr1</italic> expression is not altered in these peripheral tissues of <italic>Esr1</italic> cKO mice (<xref ref-type="bibr" rid="bib33">Herber et al., 2019</xref>), leaving the hypothalamus-POA as the most likely mediator of the ERα-dependent physiological effects of tamoxifen reported here. Despite this, it is very likely that peripheral tissues are also affected by systemic tamoxifen administration, leading to other physiological effects that we did not examine. Indeed, there is evidence that estrogen suppression therapies, including tamoxifen or aromatase inhibitors, can lead to the dysregulation of energy balance and glucose homeostasis in humans and when modeled in rodents (<xref ref-type="bibr" rid="bib52">López et al., 2006</xref>; <xref ref-type="bibr" rid="bib46">Lampert et al., 2013</xref>; <xref ref-type="bibr" rid="bib10">Ceasrine et al., 2019</xref>; <xref ref-type="bibr" rid="bib81">Scalzo et al., 2020</xref>). Together, these studies reveal widespread effects of tamoxifen treatment on the hypothalamus-POA and implicate ERα signaling within the <italic>Nkx2-1</italic> lineage as a major mediator of the effects of tamoxifen on thermoregulation, movement, and bone homeostasis.</p><p>In summary, the rodent model of tamoxifen treatment provided here mimics several of the key side effects of endocrine therapy observed in humans. If translatable to humans, our findings suggest the hypothesis that tamoxifen treatment may alter thermoregulation, physical activity, and bone through ERα signaling in the brain. A recent survey conducted in the online breast cancer communities showed that women often experienced more of tamoxifen’s side effects than men and one-third of patients did not feel that their side effects were taken seriously (<xref ref-type="bibr" rid="bib2">Berkowitz et al., 2021</xref>). The insights provided here are a first step toward the development of alternative or improved treatments that mitigate or circumvent some of the undesirable side effects of tamoxifen therapy.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or <break/>resource</th><th valign="top">Designation</th><th valign="top">Source or <break/>reference</th><th valign="top">Identifiers</th><th valign="top">Additional <break/>information</th></tr></thead><tbody><tr><td valign="top">gene (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Esr1</italic></td><td valign="top">MGI</td><td valign="top">MGI:1352467 <break/>NCBI Gene: 13982</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Esr1<sup>tm1Sakh</sup></italic> <break/><italic>Esr1 floxed</italic> mouse line; CD-1;129P2 mixed background</td><td valign="top"><xref ref-type="bibr" rid="bib24">Feng et al., 2007</xref></td><td valign="top">MGI:4459300</td><td valign="top">Targeted conditional mutation allele. Females used for experiments</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus</italic>)</td><td valign="top"><italic>Tg(Nkx2-1-cre)<sup>2Sand</sup></italic> <break/><italic>Nkx2-1Cre</italic> mouse line CD-1;129P2 mixed background</td><td valign="top"><xref ref-type="bibr" rid="bib96">Xu et al., 2008</xref></td><td valign="top">MGI: 3773076</td><td valign="top">BAC transgenic Cre driver. <break/>Females used for experiments</td></tr><tr><td valign="top">Antibody</td><td valign="top">anti-ERα (mouse monoclonal)</td><td valign="top">Santa Cruz</td><td valign="top">Cat# sc-8002, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_627558">AB_627558</ext-link></td><td valign="top">IF (1:250)</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tamoxifen</td><td valign="top">Sigma-Aldrich</td><td valign="top">T5648</td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Seurat R package</td><td valign="top"><xref ref-type="bibr" rid="bib8">Butler et al., 2018</xref></td><td valign="top">version 3.2.0</td><td valign="top">Single-cell RNA sequencing analyses</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism</td><td valign="top">GraphPad</td><td valign="top">version 8</td><td valign="top">Physiology data analyses</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">VitalView software</td><td valign="top">Starr Life Sciences</td><td valign="top">version 5.1</td><td valign="top">Core temperature and movement data collection</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Mercury Analysis Software</td><td valign="top">Star:ODDI</td><td valign="top">version 5.7</td><td valign="top">Tail temperature data collection</td></tr><tr><td valign="top">Other</td><td valign="top">DAPI stain</td><td valign="top">Invitrogen</td><td valign="top">D1306, RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:AB_2629482">AB_2629482</ext-link></td><td valign="top">IF (1 µg/mL)</td></tr></tbody></table></table-wrap><sec id="s4-1"><title>Mice</title><p>All mice were maintained under a 12:12 hr L/D schedule at room temperature (22–23°C) and provided with food and water ad libitum. Mice expressing the NK2 homeobox transcription factor 1 (<italic>Nkx2-1</italic>; also known as <italic>Ttf1</italic>) Cre driver transgene (Tg(<italic>Nkx2-1-Cre</italic>)<sup>2Sand</sup>), and the <italic>Esr1</italic> floxed allele (<italic>Esr1</italic><sup>tm1Sakh</sup>) were maintained on a CD-1;129P2 mixed background. <italic>Cre</italic>-negative littermates were selected as controls. A total of 50 female mice were used. Mice were 8–10 weeks old at the start of the experiments. All studies were carried out in accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. UCLA is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC) aThe UCLA Institutional Animal Care and Use Committee (IACUC) approved all animal procedures.</p></sec><sec id="s4-2"><title>Tamoxifen administration</title><p>Tamoxifen (Sigma-Aldrich, T5648) was dissolved first in ethanol and then diluted in corn oil at a final concentration of 100 μg/mL and 0.5% of ethanol. Accordingly, the vehicle was prepared in corn oil containing 5% ethanol. We performed daily subcutaneous injection of tamoxifen at a dose of 0.1 mg/kg or an equal volume of vehicle control for 4 weeks. We estimated that this dose models human tamoxifen exposure based on studies of tamoxifen in human serum, estimates of total blood volume in mice, and bioavailability of tamoxifen delivered via subcutaneous injection (<xref ref-type="bibr" rid="bib83">Slee et al., 1988</xref>). Additionally, it is on the low end of what is used effectively in previous studies (<xref ref-type="bibr" rid="bib91">Wade and Heller, 1993</xref>; <xref ref-type="bibr" rid="bib69">Perry et al., 2005</xref>), which is desirable to minimize off-target effects.</p></sec><sec id="s4-3"><title>Telemetry recording</title><p>Mice were anaesthetized with isofluorane and received combinatorial analgesics (0.01 mg/mL buprenorphine, 0.58 mg/mL carprofen) pre and post any surgeries. A G2 eMitter (Starr Life Sciences) was implanted to the abdominal cavity and attached to the inside body wall of a mouse. Mice were single-housed in cages placed on top of ER4000 Energizer/Receivers. Gross movement and core body temperature were measured every 5 min using VitalView software (Starr Life Sciences). These measurements were collected continuously for 3 days on and 3 days off for the duration of the 28-day period. Telemetry data show 24 hr averages from the two telemetry sessions before (baseline) and 3 weeks of tamoxifen or vehicle injections (treatment). Tail skin temperature was monitored every 5 min using a Nano-T temperature logger (Star-Oddi) that was attached to the ventral surface and 1 cm from the base of the tail in a 3D-printed polylactic acid collar modified from <xref ref-type="bibr" rid="bib43">Krajewski-Hall et al., 2018</xref>. Tail skin data show 24 hr averages for the same time periods as the telemetry data.</p></sec><sec id="s4-4"><title>Thermal imaging</title><p>Infrared thermal images were captured using e60bx thermogenic camera (FLIR Systems) and analyzed using the FLIR Tools software. All images were obtained at a constant distance to subject in awake animals at light phase. BAT skin temperature was defined from the average temperature of a spherical area centered on the interscapular region.</p></sec><sec id="s4-5"><title>Single-cell dissociation and library preparation</title><p>To avoid circadian differences and batch effects, all four groups were performed in parallel at the same time across 4 days with n = 4 mice per day. Mice were euthanized 2 hr after the last administration of tamoxifen or vehicle. The brain was freshly collected into ice-cold HABG buffer (Hibernate A, B27, Glutamax, Fisher Scientific, Hampton, NH, USA) containing freshly prepared papain. A coronal section containing the hypothalamus-POA was quickly dissected along the boundary of rostral and caudal spherical grooves from the bottom of the brain. A third cut was made along the white fiber of anterior commissure to get a square block of tissue (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1A</xref>). The tissue was then disassociated and prepared into a single-cell suspension at a concentration of 100 cells/μL in 0.01% BSA-PBS using a previously described protocol (<xref ref-type="bibr" rid="bib51">Liu et al., 2020</xref>). Briefly, dissected tissues were incubated in a papain solution for 30 min at 30°C then washed with HABG. Using a siliconized 9-in Pasteur pipette with a fire-polished tip, the cells were triturated carefully to help dissociate the tissue. Next, to separate the cells and remove debris, the cell suspension was placed on top of a prepared OptiPrep density gradient (Sigma-Aldrich, St. Louis, MO, USA) then centrifugated at 800 g for 15 min at 22°C. After debris removal, the cell suspension containing the desired cell fractions was centrifugated for 3 min at 22°C at 200 g, and the supernatant was discarded. Finally, the cell pellet was re-suspended in 0.01% BSA (in PBS) and filtered through a 40 µm strainer (Fisher Scientific, Hampton, NH, USA). The cells were then counted and diluted to appropriate cell density.</p><p>Barcoded single cells, or STAMPs (single-cell transcriptomes attached to microparticles), and cDNA libraries were prepared as described previously (<xref ref-type="bibr" rid="bib51">Liu et al., 2020</xref>) and in line with the online protocol v3.1 from McCarroll Lab (<ext-link ext-link-type="uri" xlink:href="http://mccarrolllab.org/download/905/">http://mccarrolllab.org/download/905/</ext-link>). Briefly, to generate STAMPS, the prepared single-cell suspensions, EvaGreen droplet generation oil (BIO-RAD, Hercules, CA, USA), and ChemGenes barcoded microparticles (ChemGenes, Wilmington, MA, USA) containing unique molecular identifiers (UMIs) and cell barcodes were co-flowed through a FlowJEM aquapel-treated Drop-seq microfluidic device (FlowJEM, Toronto, Canada) at recommended flow speeds (oil: 15,000 μL/h, cells: 4000 μL/h, and beads 4000 μL/h). After breakage of the droplets, the beads were washed and suspended in reverse transcriptase solution. Prior to PCR amplification, samples underwent an exonuclease I treatment. Next, the beads were washed, counted, and aliquoted into PCR tubes (6000 beads/tube) for PCR amplification (4+11 cycles). The cDNA quality was checked using a High Sensitivity chip on BioAnalyzer (Agilent, Santa Clara, CA, USA) then fragmented using Nextera DNA Library Preparation kit (Illumina, San Diego, CA, USA) with multiplex indices. The libraries were then purified, quantified, and sequenced on an Illumina HiSeq 4000 (Illumina, San Diego, CA, USA).</p></sec><sec id="s4-6"><title>Analysis of single-cell RNA-seq</title><p>Single-cell transcriptomic data were analyzed in R version 3.6.1 using the package ‘Seurat’ version 3.2.0 and custom Seurat helper package ‘ratplots’ version 0.1.0 written for this study. All custom functions and complete analysis scripts are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/jevanveen/">https://github.com/jevanveen/</ext-link>; <xref ref-type="bibr" rid="bib86">Stuart et al., 2019</xref>. Cells were filtered for quality with the following criteria: cells with &gt;15% of reads coming from mitochondrial genes were excluded and cells with fewer than 200 or more than 4000 genes detected were excluded. Samples derived from the four experimental conditions—wild-type, vehicle treated; wild-type, tamoxifen treated; <italic>Esr1 cKO</italic>, vehicle treated; and <italic>Esr1 cKO</italic>, tamoxifen treated—were aligned based on the expression of 2000 conserved highly variable markers in each group. Cells were clustered based on transcriptome similarity, using a shared nearest neighbor algorithm (<xref ref-type="bibr" rid="bib92">Waltman and van Eck, 2013</xref>) and displayed with both universal manifold approximation and projection (UMAP) and t-distributed stochastic neighbor embedding (tSNE). For each cell cluster, marker genes were determined by comparing expression in the given cluster against all other clusters using the smart local moving algorithm to iteratively group clusters together (<xref ref-type="bibr" rid="bib3">Blondel et al., 2008</xref>). For all differentially expressed gene marker analyses, statistical significance testing was performed with the Seurat default Wilcoxon rank-sum-based test and Benjamini-Hochberg method for multiple-testing correction. GSEAs were performed in R using the package ‘fgsea’ version 1.14.0. GSEAs to find estrogen signatures were done using the gene ontology (GO) pathway ‘GO_ESTROGEN_RESPONSE’ taken from mSigDB version 6.2. For general pathway analyses, a custom set of pathways was assembled from mSigDB ‘Hallmark’ pathways version 6.2 and selected GO pathways (version 6.2) particularly relevant to neural development and function. The complete list of these pathways is given in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1b</xref>.</p><p>Cells annotated as neurons were extracted and re-clustered using the same steps used to cluster all cells, with the following differences: 500 highly variable genes were used to align neurons from different treatment groups. No additional quality filtering was performed. Neuronal subtypes were annotated based on top marker genes, defined as the highest LogFC compared to all other neuronal subtypes, while meeting the criterion of adjusted p-value &lt; 0.05. GSEAs were performed on neuronal subtypes using the same gene sets and methods performed for general cell types. All graphs and tables in <xref ref-type="fig" rid="fig3">Figures 3</xref>–<xref ref-type="fig" rid="fig5">5</xref> were produced using the R packages ‘ggplot2’ version 3.3.2 and custom functions in ‘ratplots’ version 0.1.0.</p></sec><sec id="s4-7"><title>Micro-computed tomography</title><p>Left femoral bones from the hind legs were dissected, cleaned of any soft tissue, and frozen in PBS at −20°C till further analysis. Samples were scanned in 70% ethanol using Scanco Medical μCT 50 specimen scanner with a voxel size of 10 mm, an X-ray tube potential of 55 kVp and X-ray intensity of 109 μA. Scanned regions included 2 mm region of the femur proximal to epiphyseal plate and 1 mm region of the femoral mid-diaphysis. For the analysis, a trabecular bone compartment of 1 mm length proximal to the epiphyseal plate was measured. Cortical parameters were assessed at the diaphysis in an adjacent 0.4 mm region of the femur. In both specimen and in vivo scanning, volumes of interest were evaluated using Scanco evaluation software. Representative 3D images created using Scanco Medical mCT Ray v4.0 software.</p></sec><sec id="s4-8"><title>Immunohistochemistry</title><p>Mice were perfused transcardially with ice-cold PBS (pH = 7.4) followed by 4% paraformaldehyde (PFA) in PBS. Brains were post fixed in 4% PFA overnight, dehydration in 30% sucrose for 24 hr, embedded in optimal cutting temperature (OCT) compound, and stored in −80°C before sectioning. Coronal sections were cut under cryostat (Vibratome) into eight equal series at 18 μm. ERα immunoreactivity was detected using hot based antigen retrieval immunohistochemistry protocol. Briefly, sections were first incubated in antigen retrieval buffer (25 mM Tris–HCl, 1 mM EDTA, and 0.05% SDS, pH 8.5) at 95°C for 40 min. Sections were then blocked for 1 hr in 10% BSA and 2% normal goat serum (NGS) and incubated overnight at 4°C with primary antibody (ERα, 1:250, sc-8002, Santa Cruz). Following 3 × 10 min washing in PBS, sections were incubated with fluorophore conjugated goat anti-mouse secondary antibody (Thermo Fisher Scientific) for 2 hr at room temperature. After washing, sections were incubated with DAPI, washed with PBS, and coverslipped with Fluoromount-G.</p><p>The images were taken by DM1000 LED fluorescent microscope (Leica). Cyan/magenta/yellow pseudo-colors were applied to all fluorescent images for color-friendly accessibility. Image processing was performed using the Leica Application Suite (Leica) and ImageJ (NIH).</p></sec><sec id="s4-9"><title>RNA isolation and real time PCR (qPCR)</title><p>Interscapular BAT was snap-frozen in liquid nitrogen and stored at −80°C until analysis. Total RNA from BAT was isolated using Zymo RNA isolation kit (ZYMO Research) and RNA yield was determined using a NanoDrop D1000 (Thermo Fisher Scientific). cDNA synthesis was performed with equal RNA input using the Transcriptor First Strand cDNA synthesis kit (Roche Molecular Biochemicals). qPCR was performed using C1000 Touch Thermal Cycler (BioRed) and SYBR mix (Bioline, GmbH, Germany), using validated primer sets (<xref ref-type="bibr" rid="bib101">Zhang et al., 2020</xref>) (<italic>Ucp1</italic>: F - <named-content content-type="sequence">CACGGGGACCTACAATGCTT</named-content> and R – <named-content content-type="sequence">TAGGGGTCGTCCCTTTCCAA</named-content>; <italic>Adr3b</italic> F - <named-content content-type="sequence">GGAAGCTTGCTTGATCCCCA</named-content> and R - <named-content content-type="sequence">GCCGTTGCTTGTCTTTCTGG</named-content>).</p></sec><sec id="s4-10"><title>Statistics</title><p>Data are represented as mean ± standard error of the mean (SEM). Data with normal distribution and similar variance were analyzed for statistical significance using two-tailed, unpaired Student’s t-tests. Time course data were analyzed by repeated measures two-way ANOVA or mixed model followed by Sidak’s multiple comparisons. Significance was defined at a level of α &lt;0.05. Detailed statistics are listed in <xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>. Statistics were performed using GraphPad Prism eight and RStudio.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>This research was supported by V Scholar Awards (V2017-007 and DVP2020-005) from the V Foundation for Cancer Research to SMC, NIH R21CA249338 to SMC, two Pilot Awards from the Iris Cantor-UCLA Women’s Health Center/UCLA National Center of Excellence in Women’s Health and NIH National Center for Advancing Translational Science (NCATS) UCLA CTSI (UL1TR001881) to ZZ, JEV, and SMC. ZZ was supported by an American Heart Association Postdoctoral Fellowship (18POST33960457), and GD was supported by NIEHS NIH T32ES015457.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration</p></fn><fn fn-type="con" id="con2"><p>Data curation, Formal analysis, Validation, Investigation, Methodology</p></fn><fn fn-type="con" id="con3"><p>Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Validation, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Data curation, Software, Formal analysis, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Validation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con7"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con8"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn><fn fn-type="con" id="con9"><p>Conceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: These studies were performed in strict accordance with the recommendation Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to approved institutional animal care and use committee (IACUC) protocols (#2016-003B and #2016-004) at UCLA. The protocol was approved by the Animal Research Committee at UCLA. All surgery was performed under isoflurane anesthesia and every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="scode1"><label>Source code 1.</label><caption><title>R Code for scRNA-seq analyses.</title></caption><media mime-subtype="zip" mimetype="application" xlink:href="elife-63333-code1-v1.zip"/></supplementary-material><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Tables for single-cell data.</title><p>(a) Gene set enrichment analysis (GSEA) of estrogen responsive genes in cells from tamoxifen-treated vs. vehicle-treated wild-type mice. (b) List of all gene sets queried in GSEAs for (c, d, and e). (c) Pathways significantly altered in cell clusters from tamoxifen-treated vs. vehicle-treated wild-type mice. (d) Pathways significantly altered in neuronal subtypes from tamoxifen-treated vs. vehicle treated wild-type mice. (e) Pathways significantly altered in cells from tamoxifen-treated vs. vehicle-treated <italic>Esr1</italic> cKO mice, as determined by GSEA. (f) GSEA of estrogen responsive genes in cells from tamoxifen-treated vs. vehicle-treated <italic>Esr1</italic> cKO mice. (g) GSEA of estrogen responsive genes in neuronal clusters from tamoxifen-treated vs. vehicle-treated wild-type mice. (h) GSEA of estrogen responsive genes in neuronal clusters from tamoxifen-treated vs. vehicle-treated <italic>Esr1</italic> cKO mice. (i) Differentially expressed genes (DEGs) in neurons from tamoxifen-treated vs. vehicle-treated mice. (j) DEGs in ependymal cells from tamoxifen-treated vs. vehicle-treated mice.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-supp1-v1.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Details of all statistical tests for physiology data.</title><p>(a) Statistical details for <xref ref-type="fig" rid="fig1">Figure 1</xref>, panels c, e, and g. (b) Statistical details for <xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1</xref>, panels b and c. (c) Statistical details for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panels b and c. (d) Statistical details for <xref ref-type="fig" rid="fig2">Figure 2</xref>, panels e-g. (e) Statistical details for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panels b-h. (f) Statistical details for <xref ref-type="fig" rid="fig6">Figure 6</xref>, panels j and k .(g) Statistical details for <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>, panel e.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63333-supp2-v1.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-63333-transrepform-v1.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Sequencing data have been deposited in GEO under accession number GSE158960.</p><p>The following dataset was generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Ahn</surname><given-names>IS</given-names></name><name><surname>Diamante</surname><given-names>G</given-names></name><name><surname>Sivakumar</surname><given-names>N</given-names></name><name><surname>Arneson</surname><given-names>DV</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Veen</surname><given-names>JE</given-names></name><name><surname>Correa</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2021">2021</year><data-title>Hypothalamic estrogen receptor alpha mediates key side effects of tamoxifen therapy in mice</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE158960">GSE158960</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aquino</surname> <given-names>NSS</given-names></name><name><surname>Araujo-Lopes</surname> <given-names>R</given-names></name><name><surname>Batista</surname> <given-names>IAR</given-names></name><name><surname>Henriques</surname> <given-names>PC</given-names></name><name><surname>Poletini</surname> <given-names>MO</given-names></name><name><surname>Franci</surname> <given-names>CR</given-names></name><name><surname>Reis</surname> <given-names>AM</given-names></name><name><surname>Szawka</surname> <given-names>RE</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Hypothalamic effects of tamoxifen on oestrogen regulation of luteinising hormone and prolactin secretion in female rats</article-title><source>Journal of Neuroendocrinology</source><volume>28</volume><elocation-id>12338</elocation-id><pub-id pub-id-type="doi">10.1111/jne.12338</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berkowitz</surname> <given-names>MJ</given-names></name><name><surname>Thompson</surname> <given-names>CK</given-names></name><name><surname>Zibecchi</surname> <given-names>LT</given-names></name><name><surname>Lee</surname> <given-names>MK</given-names></name><name><surname>Streja</surname> <given-names>E</given-names></name><name><surname>Berkowitz</surname> <given-names>JS</given-names></name><name><surname>Wenziger</surname> <given-names>CM</given-names></name><name><surname>Baker</surname> <given-names>JL</given-names></name><name><surname>DiNome</surname> <given-names>ML</given-names></name><name><surname>Attai</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>How patients experience endocrine therapy for breast Cancer: an online survey of side effects, adherence, and medical team support</article-title><source>Journal of Cancer Survivorship</source><volume>15</volume><fpage>29</fpage><lpage>39</lpage><pub-id pub-id-type="doi">10.1007/s11764-020-00908-5</pub-id><pub-id pub-id-type="pmid">32804353</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blondel</surname> <given-names>VD</given-names></name><name><surname>Guillaume</surname> <given-names>J-L</given-names></name><name><surname>Lambiotte</surname> <given-names>R</given-names></name><name><surname>Lefebvre</surname> <given-names>E</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fast unfolding of communities in large networks</article-title><source>Journal of Statistical Mechanics: Theory and Experiment</source><volume>2008</volume><elocation-id>P10008</elocation-id><pub-id pub-id-type="doi">10.1088/1742-5468/2008/10/P10008</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowe</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>XF</given-names></name><name><surname>Kinsey-Jones</surname> <given-names>J</given-names></name><name><surname>Heyerick</surname> <given-names>A</given-names></name><name><surname>Brain</surname> <given-names>S</given-names></name><name><surname>Milligan</surname> <given-names>S</given-names></name><name><surname>O’Byrne</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The hop phytoestrogen, 8-prenylnaringenin, reverses the ovariectomy-induced rise in skin temperature in an animal model of menopausal hot flushes</article-title><source>Journal of Endocrinology</source><volume>191</volume><fpage>399</fpage><lpage>405</lpage><pub-id pub-id-type="doi">10.1677/joe.1.06919</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowen</surname> <given-names>RS</given-names></name><name><surname>Turner</surname> <given-names>MJ</given-names></name><name><surname>Lightfoot</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Sex hormone effects on physical activity levels</article-title><source>Sports Medicine</source><volume>41</volume><fpage>73</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.2165/11536860-000000000-00000</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinton</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>The healthy cell Bias of estrogen action: mitochondrial bioenergetics and neurological implications</article-title><source>Trends in Neurosciences</source><volume>31</volume><fpage>529</fpage><lpage>537</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2008.07.003</pub-id><pub-id pub-id-type="pmid">18774188</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brinton</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Estrogen-induced plasticity from cells to circuits: predictions for cognitive function</article-title><source>Trends in Pharmacological Sciences</source><volume>30</volume><fpage>212</fpage><lpage>222</lpage><pub-id pub-id-type="doi">10.1016/j.tips.2008.12.006</pub-id><pub-id pub-id-type="pmid">19299024</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>P</given-names></name><name><surname>Smibert</surname> <given-names>P</given-names></name><name><surname>Papalexi</surname> <given-names>E</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Integrating single-cell transcriptomic data across different conditions, technologies, and species</article-title><source>Nature Biotechnology</source><volume>36</volume><fpage>411</fpage><lpage>420</lpage><pub-id pub-id-type="doi">10.1038/nbt.4096</pub-id><pub-id pub-id-type="pmid">29608179</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cannon</surname> <given-names>B</given-names></name><name><surname>Nedergaard</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Brown adipose tissue: function and physiological significance</article-title><source>Physiological Reviews</source><volume>84</volume><fpage>277</fpage><lpage>359</lpage><pub-id pub-id-type="doi">10.1152/physrev.00015.2003</pub-id><pub-id pub-id-type="pmid">14715917</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ceasrine</surname> <given-names>AM</given-names></name><name><surname>Ruiz-Otero</surname> <given-names>N</given-names></name><name><surname>Lin</surname> <given-names>EE</given-names></name><name><surname>Lumelsky</surname> <given-names>DN</given-names></name><name><surname>Boehm</surname> <given-names>ED</given-names></name><name><surname>Kuruvilla</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Tamoxifen improves glucose tolerance in a delivery-, Sex-, and Strain-Dependent manner in mice</article-title><source>Endocrinology</source><volume>160</volume><fpage>782</fpage><lpage>790</lpage><pub-id pub-id-type="doi">10.1210/en.2018-00985</pub-id><pub-id pub-id-type="pmid">30759201</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>D</given-names></name><name><surname>Ye</surname> <given-names>R</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Zhu</surname> <given-names>C</given-names></name><name><surname>Tian</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Decision-making impairments in breast Cancer patients treated with tamoxifen</article-title><source>Hormones and Behavior</source><volume>66</volume><fpage>449</fpage><lpage>456</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2014.07.005</pub-id><pub-id pub-id-type="pmid">25036869</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>R</given-names></name><name><surname>Wu</surname> <given-names>X</given-names></name><name><surname>Jiang</surname> <given-names>L</given-names></name><name><surname>Zhang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Single-Cell RNA-Seq reveals hypothalamic cell diversity</article-title><source>Cell Reports</source><volume>18</volume><fpage>3227</fpage><lpage>3241</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.03.004</pub-id><pub-id pub-id-type="pmid">28355573</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chlebowski</surname> <given-names>RT</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Haque</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Adherence to endocrine therapy in breast Cancer adjuvant and prevention settings</article-title><source>Cancer Prevention Research</source><volume>7</volume><fpage>378</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1158/1940-6207.CAPR-13-0389</pub-id><pub-id pub-id-type="pmid">24441675</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Correa</surname> <given-names>SM</given-names></name><name><surname>Newstrom</surname> <given-names>DW</given-names></name><name><surname>Warne</surname> <given-names>JP</given-names></name><name><surname>Flandin</surname> <given-names>P</given-names></name><name><surname>Cheung</surname> <given-names>CC</given-names></name><name><surname>Lin-Moore</surname> <given-names>AT</given-names></name><name><surname>Pierce</surname> <given-names>AA</given-names></name><name><surname>Xu</surname> <given-names>AW</given-names></name><name><surname>Rubenstein</surname> <given-names>JL</given-names></name><name><surname>Ingraham</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>An estrogen-responsive module in the ventromedial hypothalamus selectively drives sex-specific activity in females</article-title><source>Cell Reports</source><volume>10</volume><fpage>62</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2014.12.011</pub-id><pub-id pub-id-type="pmid">25543145</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cuzick</surname> <given-names>J</given-names></name><name><surname>Forbes</surname> <given-names>JF</given-names></name><name><surname>Sestak</surname> <given-names>I</given-names></name><name><surname>Cawthorn</surname> <given-names>S</given-names></name><name><surname>Hamed</surname> <given-names>H</given-names></name><name><surname>Holli</surname> <given-names>K</given-names></name><name><surname>Howell</surname> <given-names>A</given-names></name><collab>International Breast Cancer Intervention Study I Investigators</collab></person-group><year iso-8601-date="2007">2007</year><article-title>Long-term results of tamoxifen prophylaxis for breast Cancer--96-month follow-up of the randomized IBIS-I trial</article-title><source>JNCI Journal of the National Cancer Institute</source><volume>99</volume><fpage>272</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1093/jnci/djk049</pub-id><pub-id pub-id-type="pmid">17312304</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dacks</surname> <given-names>PA</given-names></name><name><surname>Krajewski</surname> <given-names>SJ</given-names></name><name><surname>Rance</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat</article-title><source>Endocrinology</source><volume>152</volume><fpage>4894</fpage><lpage>4905</lpage><pub-id pub-id-type="doi">10.1210/en.2011-1492</pub-id><pub-id pub-id-type="pmid">22028440</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>C</given-names></name><name><surname>Godwin</surname> <given-names>J</given-names></name><name><surname>Gray</surname> <given-names>R</given-names></name><name><surname>Clarke</surname> <given-names>M</given-names></name><name><surname>Cutter</surname> <given-names>D</given-names></name><name><surname>Darby</surname> <given-names>S</given-names></name><name><surname>McGale</surname> <given-names>P</given-names></name><name><surname>Pan</surname> <given-names>HC</given-names></name><name><surname>Taylor</surname> <given-names>C</given-names></name><name><surname>Wang</surname> <given-names>YC</given-names></name><name><surname>Dowsett</surname> <given-names>M</given-names></name><name><surname>Ingle</surname> <given-names>J</given-names></name><name><surname>Peto</surname> <given-names>R</given-names></name><collab>Early Breast Cancer Trialists' Collaborative Group (EBCTCG)</collab></person-group><year iso-8601-date="2011">2011</year><article-title>Relevance of breast Cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials</article-title><source>Lancet</source><volume>378</volume><fpage>771</fpage><lpage>784</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(11)60993-8</pub-id><pub-id pub-id-type="pmid">21802721</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname> <given-names>C</given-names></name><name><surname>Pan</surname> <given-names>H</given-names></name><name><surname>Godwin</surname> <given-names>J</given-names></name><name><surname>Gray</surname> <given-names>R</given-names></name><name><surname>Arriagada</surname> <given-names>R</given-names></name><name><surname>Raina</surname> <given-names>V</given-names></name><name><surname>Abraham</surname> <given-names>M</given-names></name><name><surname>Alencar</surname> <given-names>VHM</given-names></name><name><surname>Badran</surname> <given-names>A</given-names></name><name><surname>Bonfill</surname> <given-names>X</given-names></name><name><surname>Bradbury</surname> <given-names>J</given-names></name><name><surname>Clarke</surname> <given-names>M</given-names></name><name><surname>Collins</surname> <given-names>R</given-names></name><name><surname>Davis</surname> <given-names>SR</given-names></name><name><surname>Delmestri</surname> <given-names>A</given-names></name><name><surname>Forbes</surname> <given-names>JF</given-names></name><name><surname>Haddad</surname> <given-names>P</given-names></name><name><surname>Hou</surname> <given-names>M-F</given-names></name><name><surname>Inbar</surname> <given-names>M</given-names></name><name><surname>Khaled</surname> <given-names>H</given-names></name><name><surname>Kielanowska</surname> <given-names>J</given-names></name><name><surname>Kwan</surname> <given-names>W-H</given-names></name><name><surname>Mathew</surname> <given-names>BS</given-names></name><name><surname>Mittra</surname> <given-names>I</given-names></name><name><surname>Müller</surname> <given-names>B</given-names></name><name><surname>Nicolucci</surname> <given-names>A</given-names></name><name><surname>Peralta</surname> <given-names>O</given-names></name><name><surname>Pernas</surname> <given-names>F</given-names></name><name><surname>Petruzelka</surname> <given-names>L</given-names></name><name><surname>Pienkowski</surname> <given-names>T</given-names></name><name><surname>Radhika</surname> <given-names>R</given-names></name><name><surname>Rajan</surname> <given-names>B</given-names></name><name><surname>Rubach</surname> <given-names>MT</given-names></name><name><surname>Tort</surname> <given-names>S</given-names></name><name><surname>Urrútia</surname> <given-names>G</given-names></name><name><surname>Valentini</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Peto</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast Cancer: atlas, a randomised trial</article-title><source>The Lancet</source><volume>381</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)61963-1</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Médina</surname> <given-names>P</given-names></name><name><surname>Favre</surname> <given-names>G</given-names></name><name><surname>Poirot</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Multiple targeting by the antitumor drug tamoxifen: a structure-activity study</article-title><source>Current Medicinal Chemistry. Anti-Cancer Agents</source><volume>4</volume><fpage>491</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.2174/1568011043352696</pub-id><pub-id pub-id-type="pmid">15579015</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denk</surname> <given-names>F</given-names></name><name><surname>Ramer</surname> <given-names>LM</given-names></name><name><surname>Erskine</surname> <given-names>EL</given-names></name><name><surname>Nassar</surname> <given-names>MA</given-names></name><name><surname>Bogdanov</surname> <given-names>Y</given-names></name><name><surname>Signore</surname> <given-names>M</given-names></name><name><surname>Wood</surname> <given-names>JN</given-names></name><name><surname>McMahon</surname> <given-names>SB</given-names></name><name><surname>Ramer</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Tamoxifen induces cellular stress in the nervous system by inhibiting cholesterol synthesis</article-title><source>Acta Neuropathologica Communications</source><volume>3</volume><elocation-id>74</elocation-id><pub-id pub-id-type="doi">10.1186/s40478-015-0255-6</pub-id><pub-id pub-id-type="pmid">26610346</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eberling</surname> <given-names>JL</given-names></name><name><surname>Wu</surname> <given-names>C</given-names></name><name><surname>Tong-Turnbeaugh</surname> <given-names>R</given-names></name><name><surname>Jagust</surname> <given-names>WJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Estrogen- and tamoxifen-associated effects on brain structure and function</article-title><source>NeuroImage</source><volume>21</volume><fpage>364</fpage><lpage>371</lpage><pub-id pub-id-type="doi">10.1016/j.neuroimage.2003.08.037</pub-id><pub-id pub-id-type="pmid">14741674</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fahrbach</surname> <given-names>SE</given-names></name><name><surname>Meisel</surname> <given-names>RL</given-names></name><name><surname>Pfaff</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="1985">1985</year><article-title>Preoptic implants of estradiol increase wheel running but not the open field activity of female rats</article-title><source>Physiology &amp; Behavior</source><volume>35</volume><fpage>985</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1016/0031-9384(85)90270-7</pub-id><pub-id pub-id-type="pmid">4095192</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farman</surname> <given-names>HH</given-names></name><name><surname>Windahl</surname> <given-names>SH</given-names></name><name><surname>Westberg</surname> <given-names>L</given-names></name><name><surname>Isaksson</surname> <given-names>H</given-names></name><name><surname>Egecioglu</surname> <given-names>E</given-names></name><name><surname>Schele</surname> <given-names>E</given-names></name><name><surname>Ryberg</surname> <given-names>H</given-names></name><name><surname>Jansson</surname> <given-names>JO</given-names></name><name><surname>Tuukkanen</surname> <given-names>J</given-names></name><name><surname>Koskela</surname> <given-names>A</given-names></name><name><surname>Xie</surname> <given-names>SK</given-names></name><name><surname>Hahner</surname> <given-names>L</given-names></name><name><surname>Zehr</surname> <given-names>J</given-names></name><name><surname>Clegg</surname> <given-names>DJ</given-names></name><name><surname>Lagerquist</surname> <given-names>MK</given-names></name><name><surname>Ohlsson</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Female mice lacking estrogen Receptor-α in hypothalamic proopiomelanocortin (POMC) Neurons display enhanced estrogenic response on cortical bone mass</article-title><source>Endocrinology</source><volume>157</volume><fpage>3242</fpage><lpage>3252</lpage><pub-id pub-id-type="doi">10.1210/en.2016-1181</pub-id><pub-id pub-id-type="pmid">27254004</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Manka</surname> <given-names>D</given-names></name><name><surname>Wagner</surname> <given-names>KU</given-names></name><name><surname>Khan</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Estrogen receptor-alpha expression in the mammary epithelium is required for ductal and alveolar morphogenesis in mice</article-title><source>PNAS</source><volume>104</volume><fpage>14718</fpage><lpage>14723</lpage><pub-id pub-id-type="doi">10.1073/pnas.0706933104</pub-id><pub-id pub-id-type="pmid">17785410</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fisher</surname> <given-names>B</given-names></name><name><surname>Costantino</surname> <given-names>JP</given-names></name><name><surname>Wickerham</surname> <given-names>DL</given-names></name><name><surname>Redmond</surname> <given-names>CK</given-names></name><name><surname>Kavanah</surname> <given-names>M</given-names></name><name><surname>Cronin</surname> <given-names>WM</given-names></name><name><surname>Vogel</surname> <given-names>V</given-names></name><name><surname>Robidoux</surname> <given-names>A</given-names></name><name><surname>Dimitrov</surname> <given-names>N</given-names></name><name><surname>Atkins</surname> <given-names>J</given-names></name><name><surname>Daly</surname> <given-names>M</given-names></name><name><surname>Wieand</surname> <given-names>S</given-names></name><name><surname>Tan-Chiu</surname> <given-names>E</given-names></name><name><surname>Ford</surname> <given-names>L</given-names></name><name><surname>Wolmark</surname> <given-names>N</given-names></name><collab>Bowel Project Investigators</collab></person-group><year iso-8601-date="1998">1998</year><article-title>Tamoxifen for prevention of breast Cancer: report of the national surgical adjuvant breast and bowel project P-1 study</article-title><source>JNCI: Journal of the National Cancer Institute</source><volume>90</volume><fpage>1371</fpage><lpage>1388</lpage><pub-id pub-id-type="doi">10.1093/jnci/90.18.1371</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francis</surname> <given-names>PA</given-names></name><name><surname>Regan</surname> <given-names>MM</given-names></name><name><surname>Fleming</surname> <given-names>GF</given-names></name><name><surname>Láng</surname> <given-names>I</given-names></name><name><surname>Ciruelos</surname> <given-names>E</given-names></name><name><surname>Bellet</surname> <given-names>M</given-names></name><name><surname>Bonnefoi</surname> <given-names>HR</given-names></name><name><surname>Climent</surname> <given-names>MA</given-names></name><name><surname>Da Prada</surname> <given-names>GA</given-names></name><name><surname>Burstein</surname> <given-names>HJ</given-names></name><name><surname>Martino</surname> <given-names>S</given-names></name><name><surname>Davidson</surname> <given-names>NE</given-names></name><name><surname>Geyer</surname> <given-names>CE</given-names></name><name><surname>Walley</surname> <given-names>BA</given-names></name><name><surname>Coleman</surname> <given-names>R</given-names></name><name><surname>Kerbrat</surname> <given-names>P</given-names></name><name><surname>Buchholz</surname> <given-names>S</given-names></name><name><surname>Ingle</surname> <given-names>JN</given-names></name><name><surname>Winer</surname> <given-names>EP</given-names></name><name><surname>Rabaglio-Poretti</surname> <given-names>M</given-names></name><name><surname>Maibach</surname> <given-names>R</given-names></name><name><surname>Ruepp</surname> <given-names>B</given-names></name><name><surname>Giobbie-Hurder</surname> <given-names>A</given-names></name><name><surname>Price</surname> <given-names>KN</given-names></name><name><surname>Colleoni</surname> <given-names>M</given-names></name><name><surname>Viale</surname> <given-names>G</given-names></name><name><surname>Coates</surname> <given-names>AS</given-names></name><name><surname>Goldhirsch</surname> <given-names>A</given-names></name><name><surname>Gelber</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Adjuvant ovarian suppression in premenopausal breast Cancer</article-title><source>New England Journal of Medicine</source><volume>372</volume><fpage>436</fpage><lpage>446</lpage><pub-id pub-id-type="doi">10.1056/NEJMoa1412379</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friese</surname> <given-names>CR</given-names></name><name><surname>Pini</surname> <given-names>TM</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Abrahamse</surname> <given-names>PH</given-names></name><name><surname>Graff</surname> <given-names>JJ</given-names></name><name><surname>Hamilton</surname> <given-names>AS</given-names></name><name><surname>Jagsi</surname> <given-names>R</given-names></name><name><surname>Janz</surname> <given-names>NK</given-names></name><name><surname>Hawley</surname> <given-names>ST</given-names></name><name><surname>Katz</surname> <given-names>SJ</given-names></name><name><surname>Griggs</surname> <given-names>JJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast Cancer</article-title><source>Breast Cancer Research and Treatment</source><volume>138</volume><fpage>931</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1007/s10549-013-2499-9</pub-id><pub-id pub-id-type="pmid">23542957</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibbs</surname> <given-names>RB</given-names></name><name><surname>Nelson</surname> <given-names>D</given-names></name><name><surname>Hammond</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of GPR30 in mediating estradiol effects on acetylcholine release in the Hippocampus</article-title><source>Hormones and Behavior</source><volume>66</volume><fpage>339</fpage><lpage>345</lpage><pub-id pub-id-type="doi">10.1016/j.yhbeh.2014.06.002</pub-id><pub-id pub-id-type="pmid">24928571</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gierach</surname> <given-names>GL</given-names></name><name><surname>Curtis</surname> <given-names>RE</given-names></name><name><surname>Pfeiffer</surname> <given-names>RM</given-names></name><name><surname>Mullooly</surname> <given-names>M</given-names></name><name><surname>Ntowe</surname> <given-names>EA</given-names></name><name><surname>Hoover</surname> <given-names>RN</given-names></name><name><surname>Nyante</surname> <given-names>SJ</given-names></name><name><surname>Feigelson</surname> <given-names>HS</given-names></name><name><surname>Glass</surname> <given-names>AG</given-names></name><name><surname>Berrington de Gonzalez</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Association of adjuvant tamoxifen and aromatase inhibitor therapy with contralateral breast Cancer risk among US women with breast Cancer in a general community setting</article-title><source>JAMA Oncology</source><volume>3</volume><fpage>186</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1001/jamaoncol.2016.3340</pub-id><pub-id pub-id-type="pmid">27711920</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gofflot</surname> <given-names>F</given-names></name><name><surname>Chartoire</surname> <given-names>N</given-names></name><name><surname>Vasseur</surname> <given-names>L</given-names></name><name><surname>Heikkinen</surname> <given-names>S</given-names></name><name><surname>Dembele</surname> <given-names>D</given-names></name><name><surname>Le Merrer</surname> <given-names>J</given-names></name><name><surname>Auwerx</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Systematic gene expression mapping clusters nuclear receptors according to their function in the brain</article-title><source>Cell</source><volume>131</volume><fpage>405</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.09.012</pub-id><pub-id pub-id-type="pmid">17956739</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Gordon</surname> <given-names>CJ</given-names></name></person-group><year iso-8601-date="1993">1993</year><source>Temperature Regulation in Laboratory Rodents</source><publisher-loc>Cambridge</publisher-loc><publisher-name>Cambridge University Press</publisher-name><pub-id pub-id-type="doi">10.1017/CBO9780511565595</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghighat</surname> <given-names>S</given-names></name><name><surname>Akbari</surname> <given-names>ME</given-names></name><name><surname>Holakouei</surname> <given-names>K</given-names></name><name><surname>Rahimi</surname> <given-names>A</given-names></name><name><surname>Montazeri</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Factors predicting fatigue in breast Cancer patients</article-title><source>Supportive Care in Cancer</source><volume>11</volume><fpage>533</fpage><lpage>538</lpage><pub-id pub-id-type="doi">10.1007/s00520-003-0473-5</pub-id><pub-id pub-id-type="pmid">12730728</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herber</surname> <given-names>CB</given-names></name><name><surname>Krause</surname> <given-names>WC</given-names></name><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Bayrer</surname> <given-names>JR</given-names></name><name><surname>Li</surname> <given-names>A</given-names></name><name><surname>Schmitz</surname> <given-names>M</given-names></name><name><surname>Fields</surname> <given-names>A</given-names></name><name><surname>Ford</surname> <given-names>B</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Reid</surname> <given-names>MS</given-names></name><name><surname>Nomura</surname> <given-names>DK</given-names></name><name><surname>Nissenson</surname> <given-names>RA</given-names></name><name><surname>Correa</surname> <given-names>SM</given-names></name><name><surname>Ingraham</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Estrogen signaling in arcuate Kiss1 neurons suppresses a sex-dependent female circuit promoting dense strong bones</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>163</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-018-08046-4</pub-id><pub-id pub-id-type="pmid">30635563</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname> <given-names>A</given-names></name><name><surname>Cuzick</surname> <given-names>J</given-names></name><name><surname>Baum</surname> <given-names>M</given-names></name><name><surname>Buzdar</surname> <given-names>A</given-names></name><name><surname>Dowsett</surname> <given-names>M</given-names></name><name><surname>Forbes</surname> <given-names>JF</given-names></name><name><surname>Hoctin-Boes</surname> <given-names>G</given-names></name><name><surname>Houghton</surname> <given-names>J</given-names></name><name><surname>Locker</surname> <given-names>GY</given-names></name><name><surname>Tobias</surname> <given-names>JS</given-names></name><collab>ATAC Trialists' Group</collab></person-group><year iso-8601-date="2005">2005</year><article-title>Results of the ATAC (Arimidex, tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for breast Cancer</article-title><source>Lancet</source><volume>365</volume><fpage>60</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)17666-6</pub-id><pub-id pub-id-type="pmid">15639680</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Isensee</surname> <given-names>J</given-names></name><name><surname>Meoli</surname> <given-names>L</given-names></name><name><surname>Zazzu</surname> <given-names>V</given-names></name><name><surname>Nabzdyk</surname> <given-names>C</given-names></name><name><surname>Witt</surname> <given-names>H</given-names></name><name><surname>Soewarto</surname> <given-names>D</given-names></name><name><surname>Effertz</surname> <given-names>K</given-names></name><name><surname>Fuchs</surname> <given-names>H</given-names></name><name><surname>Gailus-Durner</surname> <given-names>V</given-names></name><name><surname>Busch</surname> <given-names>D</given-names></name><name><surname>Adler</surname> <given-names>T</given-names></name><name><surname>de Angelis</surname> <given-names>MH</given-names></name><name><surname>Irgang</surname> <given-names>M</given-names></name><name><surname>Otto</surname> <given-names>C</given-names></name><name><surname>Noppinger</surname> <given-names>PR</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Expression pattern of G Protein-Coupled receptor 30 in LacZ reporter mice</article-title><source>Endocrinology</source><volume>150</volume><fpage>1722</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.1210/en.2008-1488</pub-id><pub-id pub-id-type="pmid">19095739</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jayasena</surname> <given-names>CN</given-names></name><name><surname>Comninos</surname> <given-names>AN</given-names></name><name><surname>Stefanopoulou</surname> <given-names>E</given-names></name><name><surname>Buckley</surname> <given-names>A</given-names></name><name><surname>Narayanaswamy</surname> <given-names>S</given-names></name><name><surname>Izzi-Engbeaya</surname> <given-names>C</given-names></name><name><surname>Abbara</surname> <given-names>A</given-names></name><name><surname>Ratnasabapathy</surname> <given-names>R</given-names></name><name><surname>Mogford</surname> <given-names>J</given-names></name><name><surname>Ng</surname> <given-names>N</given-names></name><name><surname>Sarang</surname> <given-names>Z</given-names></name><name><surname>Ghatei</surname> <given-names>MA</given-names></name><name><surname>Bloom</surname> <given-names>SR</given-names></name><name><surname>Hunter</surname> <given-names>MS</given-names></name><name><surname>Dhillo</surname> <given-names>WS</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Neurokinin B administration induces hot flushes in women</article-title><source>Scientific Reports</source><volume>5</volume><elocation-id>8466</elocation-id><pub-id pub-id-type="doi">10.1038/srep08466</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname> <given-names>VC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tamoxifen: a most unlikely pioneering medicine</article-title><source>Nature Reviews Drug Discovery</source><volume>2</volume><fpage>205</fpage><lpage>213</lpage><pub-id pub-id-type="doi">10.1038/nrd1031</pub-id><pub-id pub-id-type="pmid">12612646</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jordan</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast Cancer</article-title><source>Steroids</source><volume>72</volume><fpage>829</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1016/j.steroids.2007.07.009</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>DW</given-names></name><name><surname>Yao</surname> <given-names>Z</given-names></name><name><surname>Graybuck</surname> <given-names>LT</given-names></name><name><surname>Kim</surname> <given-names>TK</given-names></name><name><surname>Nguyen</surname> <given-names>TN</given-names></name><name><surname>Smith</surname> <given-names>KA</given-names></name><name><surname>Fong</surname> <given-names>O</given-names></name><name><surname>Yi</surname> <given-names>L</given-names></name><name><surname>Koulena</surname> <given-names>N</given-names></name><name><surname>Pierson</surname> <given-names>N</given-names></name><name><surname>Shah</surname> <given-names>S</given-names></name><name><surname>Lo</surname> <given-names>L</given-names></name><name><surname>Pool</surname> <given-names>AH</given-names></name><name><surname>Oka</surname> <given-names>Y</given-names></name><name><surname>Pachter</surname> <given-names>L</given-names></name><name><surname>Cai</surname> <given-names>L</given-names></name><name><surname>Tasic</surname> <given-names>B</given-names></name><name><surname>Zeng</surname> <given-names>H</given-names></name><name><surname>Anderson</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Multimodal analysis of cell types in a hypothalamic node controlling social behavior</article-title><source>Cell</source><volume>179</volume><fpage>713</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.09.020</pub-id><pub-id pub-id-type="pmid">31626771</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="1979">1979</year><article-title>Effects of lesions of the Amygdala, preoptic area, and hypothalamus on estradiol-induced activity in the female rat</article-title><source>Journal of Comparative and Physiological Psychology</source><volume>93</volume><fpage>360</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1037/h0077559</pub-id><pub-id pub-id-type="pmid">457955</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kligman</surname> <given-names>L</given-names></name><name><surname>Younus</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Management of hot flashes in women with breast Cancer</article-title><source>Current Oncology</source><volume>17</volume><fpage>81</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.3747/co.v17i1.473</pub-id><pub-id pub-id-type="pmid">20179808</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname> <given-names>T</given-names></name><name><surname>Tamura</surname> <given-names>M</given-names></name><name><surname>Hayashi</surname> <given-names>M</given-names></name><name><surname>Katsuura</surname> <given-names>Y</given-names></name><name><surname>Tanabe</surname> <given-names>H</given-names></name><name><surname>Ohta</surname> <given-names>T</given-names></name><name><surname>Komoriya</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Elevation of tail skin temperature in ovariectomized rats in relation to menopausal hot flushes</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>278</volume><fpage>R863</fpage><lpage>R869</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.2000.278.4.R863</pub-id><pub-id pub-id-type="pmid">10749773</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajewski-Hall</surname> <given-names>SJ</given-names></name><name><surname>Blackmore</surname> <given-names>EM</given-names></name><name><surname>McMinn</surname> <given-names>JR</given-names></name><name><surname>Rance</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Estradiol alters body temperature regulation in the female mouse</article-title><source>Temperature</source><volume>5</volume><fpage>56</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1080/23328940.2017.1384090</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Krause</surname> <given-names>WC</given-names></name><name><surname>Rodriguez</surname> <given-names>R</given-names></name><name><surname>Gegenhuber</surname> <given-names>B</given-names></name><name><surname>Matharu</surname> <given-names>N</given-names></name><name><surname>Rodriguez</surname> <given-names>AN</given-names></name><name><surname>Padilla</surname> <given-names>AM</given-names></name><name><surname>Herber</surname> <given-names>CB</given-names></name><name><surname>Correa</surname> <given-names>SM</given-names></name><name><surname>Ahituv</surname> <given-names>N</given-names></name><name><surname>Tollkuhn</surname> <given-names>J</given-names></name><name><surname>Ingraham</surname> <given-names>HA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Estrogen drives melanocortin neurons to reduce sedentary behavior</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/794792</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kristensen</surname> <given-names>B</given-names></name><name><surname>Ejlertsen</surname> <given-names>B</given-names></name><name><surname>Dalgaard</surname> <given-names>P</given-names></name><name><surname>Larsen</surname> <given-names>L</given-names></name><name><surname>Holmegaard</surname> <given-names>SN</given-names></name><name><surname>Transbøl</surname> <given-names>I</given-names></name><name><surname>Mouridsen</surname> <given-names>HT</given-names></name></person-group><year iso-8601-date="1994">1994</year><article-title>Tamoxifen and bone metabolism in postmenopausal low-risk breast Cancer patients: a randomized study</article-title><source>Journal of Clinical Oncology</source><volume>12</volume><fpage>992</fpage><lpage>997</lpage><pub-id pub-id-type="doi">10.1200/JCO.1994.12.5.992</pub-id><pub-id pub-id-type="pmid">8164053</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lampert</surname> <given-names>C</given-names></name><name><surname>Arcego</surname> <given-names>DM</given-names></name><name><surname>Laureano</surname> <given-names>DP</given-names></name><name><surname>Diehl</surname> <given-names>LA</given-names></name><name><surname>da Costa Lima</surname> <given-names>IF</given-names></name><name><surname>Krolow</surname> <given-names>R</given-names></name><name><surname>Pettenuzzo</surname> <given-names>LF</given-names></name><name><surname>Dalmaz</surname> <given-names>C</given-names></name><name><surname>Vendite</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Effect of chronic administration of tamoxifen and/or estradiol on feeding behavior, palatable food and metabolic parameters in ovariectomized rats</article-title><source>Physiology &amp; Behavior</source><volume>119</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1016/j.physbeh.2013.05.026</pub-id><pub-id pub-id-type="pmid">23688948</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CM</given-names></name><name><surname>Zhou</surname> <given-names>L</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>J</given-names></name><name><surname>Geng</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Su</surname> <given-names>X</given-names></name><name><surname>Barad</surname> <given-names>N</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>YE</given-names></name><name><surname>Lin</surname> <given-names>Q</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA-seq analysis revealed long-lasting adverse effects of tamoxifen on neurogenesis in prenatal and adult brains</article-title><source>PNAS</source><volume>117</volume><fpage>19578</fpage><lpage>19589</lpage><pub-id pub-id-type="doi">10.1073/pnas.1918883117</pub-id><pub-id pub-id-type="pmid">32727894</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lien</surname> <given-names>EA</given-names></name><name><surname>Wester</surname> <given-names>K</given-names></name><name><surname>Lønning</surname> <given-names>PE</given-names></name><name><surname>Solheim</surname> <given-names>E</given-names></name><name><surname>Ueland</surname> <given-names>PM</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Distribution of tamoxifen and metabolites into brain tissue and brain metastases in breast Cancer patients</article-title><source>British Journal of Cancer</source><volume>63</volume><fpage>641</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1038/bjc.1991.147</pub-id><pub-id pub-id-type="pmid">2021551</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lightfoot</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Sex hormones' regulation of rodent physical activity: a review</article-title><source>International Journal of Biological Sciences</source><volume>4</volume><fpage>126</fpage><lpage>132</lpage><pub-id pub-id-type="doi">10.7150/ijbs.4.126</pub-id><pub-id pub-id-type="pmid">18449357</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindberg</surname> <given-names>MK</given-names></name><name><surname>Weihua</surname> <given-names>Z</given-names></name><name><surname>Andersson</surname> <given-names>N</given-names></name><name><surname>Moverare</surname> <given-names>S</given-names></name><name><surname>Gao</surname> <given-names>H</given-names></name><name><surname>Vidal</surname> <given-names>O</given-names></name><name><surname>Erlandsson</surname> <given-names>M</given-names></name><name><surname>Windahl</surname> <given-names>S</given-names></name><name><surname>Andersson</surname> <given-names>G</given-names></name><name><surname>Lubahn</surname> <given-names>DB</given-names></name><name><surname>Carlsten</surname> <given-names>H</given-names></name><name><surname>Dahlman-Wright</surname> <given-names>K</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name><name><surname>Ohlsson</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Estrogen receptor specificity for the effects of estrogen in ovariectomized mice</article-title><source>Journal of Endocrinology</source><volume>174</volume><fpage>167</fpage><lpage>178</lpage><pub-id pub-id-type="doi">10.1677/joe.0.1740167</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Venugopal</surname> <given-names>S</given-names></name><name><surname>Majid</surname> <given-names>S</given-names></name><name><surname>Ahn</surname> <given-names>IS</given-names></name><name><surname>Diamante</surname> <given-names>G</given-names></name><name><surname>Hong</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Chandler</surname> <given-names>SH</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Single-cell RNA-seq analysis of the brainstem of mutant SOD1 mice reveals perturbed cell types and pathways of amyotrophic lateral sclerosis</article-title><source>Neurobiology of Disease</source><volume>141</volume><elocation-id>104877</elocation-id><pub-id pub-id-type="doi">10.1016/j.nbd.2020.104877</pub-id><pub-id pub-id-type="pmid">32360664</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López</surname> <given-names>M</given-names></name><name><surname>Lelliott</surname> <given-names>CJ</given-names></name><name><surname>Tovar</surname> <given-names>S</given-names></name><name><surname>Kimber</surname> <given-names>W</given-names></name><name><surname>Gallego</surname> <given-names>R</given-names></name><name><surname>Virtue</surname> <given-names>S</given-names></name><name><surname>Blount</surname> <given-names>M</given-names></name><name><surname>Vázquez</surname> <given-names>MJ</given-names></name><name><surname>Finer</surname> <given-names>N</given-names></name><name><surname>Powles</surname> <given-names>TJ</given-names></name><name><surname>O'Rahilly</surname> <given-names>S</given-names></name><name><surname>Saha</surname> <given-names>AK</given-names></name><name><surname>Diéguez</surname> <given-names>C</given-names></name><name><surname>Vidal-Puig</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA</article-title><source>Diabetes</source><volume>55</volume><fpage>1327</fpage><lpage>1336</lpage><pub-id pub-id-type="doi">10.2337/db05-1356</pub-id><pub-id pub-id-type="pmid">16644689</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loprinzi</surname> <given-names>CL</given-names></name><name><surname>Zahasky</surname> <given-names>KM</given-names></name><name><surname>Sloan</surname> <given-names>JA</given-names></name><name><surname>Novotny</surname> <given-names>PJ</given-names></name><name><surname>Quella</surname> <given-names>SK</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Tamoxifen-induced hot flashes</article-title><source>Clinical Breast Cancer</source><volume>1</volume><fpage>52</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.3816/CBC.2000.n.004</pub-id><pub-id pub-id-type="pmid">11899390</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>RR</given-names></name><name><surname>Cameron</surname> <given-names>L</given-names></name><name><surname>Connell</surname> <given-names>BL</given-names></name><name><surname>Leventhal</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="1991">1991</year><article-title>Symptoms associated with tamoxifen treatment in postmenopausal women</article-title><source>Archives of Internal Medicine</source><volume>151</volume><fpage>1842</fpage><lpage>1847</lpage><pub-id pub-id-type="doi">10.1001/archinte.1991.00400090120021</pub-id><pub-id pub-id-type="pmid">1888251</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>RR</given-names></name><name><surname>Mazess</surname> <given-names>RB</given-names></name><name><surname>Barden</surname> <given-names>HS</given-names></name><name><surname>Epstein</surname> <given-names>S</given-names></name><name><surname>Newcomb</surname> <given-names>PA</given-names></name><name><surname>Jordan</surname> <given-names>VC</given-names></name><name><surname>Carbone</surname> <given-names>PP</given-names></name><name><surname>DeMets</surname> <given-names>DL</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Effects of tamoxifen on bone mineral density in postmenopausal women with breast Cancer</article-title><source>New England Journal of Medicine</source><volume>326</volume><fpage>852</fpage><lpage>856</lpage><pub-id pub-id-type="doi">10.1056/NEJM199203263261302</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macosko</surname> <given-names>EZ</given-names></name><name><surname>Basu</surname> <given-names>A</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name><name><surname>Nemesh</surname> <given-names>J</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Goldman</surname> <given-names>M</given-names></name><name><surname>Tirosh</surname> <given-names>I</given-names></name><name><surname>Bialas</surname> <given-names>AR</given-names></name><name><surname>Kamitaki</surname> <given-names>N</given-names></name><name><surname>Martersteck</surname> <given-names>EM</given-names></name><name><surname>Trombetta</surname> <given-names>JJ</given-names></name><name><surname>Weitz</surname> <given-names>DA</given-names></name><name><surname>Sanes</surname> <given-names>JR</given-names></name><name><surname>Shalek</surname> <given-names>AK</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Highly parallel Genome-wide expression profiling of individual cells using nanoliter droplets</article-title><source>Cell</source><volume>161</volume><fpage>1202</fpage><lpage>1214</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2015.05.002</pub-id><pub-id pub-id-type="pmid">26000488</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martínez de Morentin</surname> <given-names>PB</given-names></name><name><surname>González-García</surname> <given-names>I</given-names></name><name><surname>Martins</surname> <given-names>L</given-names></name><name><surname>Lage</surname> <given-names>R</given-names></name><name><surname>Fernández-Mallo</surname> <given-names>D</given-names></name><name><surname>Martínez-Sánchez</surname> <given-names>N</given-names></name><name><surname>Ruíz-Pino</surname> <given-names>F</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Morgan</surname> <given-names>DA</given-names></name><name><surname>Pinilla</surname> <given-names>L</given-names></name><name><surname>Gallego</surname> <given-names>R</given-names></name><name><surname>Saha</surname> <given-names>AK</given-names></name><name><surname>Kalsbeek</surname> <given-names>A</given-names></name><name><surname>Fliers</surname> <given-names>E</given-names></name><name><surname>Bisschop</surname> <given-names>PH</given-names></name><name><surname>Diéguez</surname> <given-names>C</given-names></name><name><surname>Nogueiras</surname> <given-names>R</given-names></name><name><surname>Rahmouni</surname> <given-names>K</given-names></name><name><surname>Tena-Sempere</surname> <given-names>M</given-names></name><name><surname>López</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Estradiol regulates Brown adipose tissue thermogenesis via hypothalamic AMPK</article-title><source>Cell Metabolism</source><volume>20</volume><fpage>41</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2014.03.031</pub-id><pub-id pub-id-type="pmid">24856932</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>KI</given-names></name><name><surname>Yanagisawa</surname> <given-names>M</given-names></name><name><surname>Sano</surname> <given-names>K</given-names></name><name><surname>Ochiai</surname> <given-names>I</given-names></name><name><surname>Musatov</surname> <given-names>S</given-names></name><name><surname>Okoshi</surname> <given-names>K</given-names></name><name><surname>Tsukahara</surname> <given-names>S</given-names></name><name><surname>Ogawa</surname> <given-names>S</given-names></name><name><surname>Kawata</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Visualisation and characterisation of oestrogen receptor α-positive neurons expressing green fluorescent protein under the control of the oestrogen receptor α promoter</article-title><source>European Journal of Neuroscience</source><volume>38</volume><fpage>2242</fpage><lpage>2249</lpage><pub-id pub-id-type="doi">10.1111/ejn.12227</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mauvais-Jarvis</surname> <given-names>F</given-names></name><name><surname>Clegg</surname> <given-names>DJ</given-names></name><name><surname>Hevener</surname> <given-names>AL</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The role of estrogens in control of energy balance and glucose homeostasis</article-title><source>Endocrine Reviews</source><volume>34</volume><fpage>309</fpage><lpage>338</lpage><pub-id pub-id-type="doi">10.1210/er.2012-1055</pub-id><pub-id pub-id-type="pmid">23460719</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merchenthaler</surname> <given-names>I</given-names></name><name><surname>Lane</surname> <given-names>MV</given-names></name><name><surname>Numan</surname> <given-names>S</given-names></name><name><surname>Dellovade</surname> <given-names>TL</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses</article-title><source>The Journal of Comparative Neurology</source><volume>473</volume><fpage>270</fpage><lpage>291</lpage><pub-id pub-id-type="doi">10.1002/cne.20128</pub-id><pub-id pub-id-type="pmid">15101093</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mittelman-Smith</surname> <given-names>MA</given-names></name><name><surname>Williams</surname> <given-names>H</given-names></name><name><surname>Krajewski-Hall</surname> <given-names>SJ</given-names></name><name><surname>McMullen</surname> <given-names>NT</given-names></name><name><surname>Rance</surname> <given-names>NE</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Role for kisspeptin/neurokinin B/dynorphin (KNDy) neurons in cutaneous vasodilatation and the estrogen modulation of body temperature</article-title><source>PNAS</source><volume>109</volume><fpage>19846</fpage><lpage>19851</lpage><pub-id pub-id-type="doi">10.1073/pnas.1211517109</pub-id><pub-id pub-id-type="pmid">23150555</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mo</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Yang</surname> <given-names>F</given-names></name><name><surname>Luo</surname> <given-names>H</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Tu</surname> <given-names>G</given-names></name><name><surname>Yang</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast Cancer</article-title><source>Breast Cancer Research</source><volume>15</volume><elocation-id>R114</elocation-id><pub-id pub-id-type="doi">10.1186/bcr3581</pub-id><pub-id pub-id-type="pmid">24289103</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moffitt</surname> <given-names>JR</given-names></name><name><surname>Bambah-Mukku</surname> <given-names>D</given-names></name><name><surname>Eichhorn</surname> <given-names>SW</given-names></name><name><surname>Vaughn</surname> <given-names>E</given-names></name><name><surname>Shekhar</surname> <given-names>K</given-names></name><name><surname>Perez</surname> <given-names>JD</given-names></name><name><surname>Rubinstein</surname> <given-names>ND</given-names></name><name><surname>Hao</surname> <given-names>J</given-names></name><name><surname>Regev</surname> <given-names>A</given-names></name><name><surname>Dulac</surname> <given-names>C</given-names></name><name><surname>Zhuang</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular, spatial, and functional single-cell profiling of the hypothalamic preoptic region</article-title><source>Science</source><volume>362</volume><elocation-id>eaau5324</elocation-id><pub-id pub-id-type="doi">10.1126/science.aau5324</pub-id><pub-id pub-id-type="pmid">30385464</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Musatov</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>W</given-names></name><name><surname>Pfaff</surname> <given-names>DW</given-names></name><name><surname>Mobbs</surname> <given-names>CV</given-names></name><name><surname>Yang</surname> <given-names>XJ</given-names></name><name><surname>Clegg</surname> <given-names>DJ</given-names></name><name><surname>Kaplitt</surname> <given-names>MG</given-names></name><name><surname>Ogawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Silencing of estrogen receptor alpha in the ventromedial nucleus of hypothalamus leads to metabolic syndrome</article-title><source>PNAS</source><volume>104</volume><fpage>2501</fpage><lpage>2506</lpage><pub-id pub-id-type="doi">10.1073/pnas.0610787104</pub-id><pub-id pub-id-type="pmid">17284595</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogawa</surname> <given-names>S</given-names></name><name><surname>Chan</surname> <given-names>J</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name><name><surname>Korach</surname> <given-names>KS</given-names></name><name><surname>Pfaff</surname> <given-names>DW</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity</article-title><source>Endocrinology</source><volume>144</volume><fpage>230</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1210/en.2002-220519</pub-id><pub-id pub-id-type="pmid">12488349</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opas</surname> <given-names>EE</given-names></name><name><surname>Scafonas</surname> <given-names>A</given-names></name><name><surname>Nantermet</surname> <given-names>PV</given-names></name><name><surname>Wilkening</surname> <given-names>RR</given-names></name><name><surname>Birzin</surname> <given-names>ET</given-names></name><name><surname>Wilkinson</surname> <given-names>H</given-names></name><name><surname>Colwell</surname> <given-names>LF</given-names></name><name><surname>Schaeffer</surname> <given-names>JM</given-names></name><name><surname>Towler</surname> <given-names>DA</given-names></name><name><surname>Rodan</surname> <given-names>GA</given-names></name><name><surname>Schmidt</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Control of rat tail skin temperature regulation by estrogen receptor-beta selective ligand</article-title><source>Maturitas</source><volume>64</volume><fpage>46</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2009.07.007</pub-id><pub-id pub-id-type="pmid">19679413</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Padilla</surname> <given-names>SL</given-names></name><name><surname>Johnson</surname> <given-names>CW</given-names></name><name><surname>Barker</surname> <given-names>FD</given-names></name><name><surname>Patterson</surname> <given-names>MA</given-names></name><name><surname>Palmiter</surname> <given-names>RD</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>A neural circuit underlying the generation of hot flushes</article-title><source>Cell Reports</source><volume>24</volume><fpage>271</fpage><lpage>277</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.06.037</pub-id><pub-id pub-id-type="pmid">29996088</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patisaul</surname> <given-names>HB</given-names></name><name><surname>Aultman</surname> <given-names>EA</given-names></name><name><surname>Bielsky</surname> <given-names>IF</given-names></name><name><surname>Young</surname> <given-names>LJ</given-names></name><name><surname>Wilson</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Immediate and residual effects of tamoxifen and ethynylestradiol in the female rat hypothalamus</article-title><source>Brain Research</source><volume>978</volume><fpage>185</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1016/S0006-8993(03)02807-5</pub-id><pub-id pub-id-type="pmid">12834913</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname> <given-names>MJ</given-names></name><name><surname>Gujra</surname> <given-names>S</given-names></name><name><surname>Whitworth</surname> <given-names>T</given-names></name><name><surname>Tobias</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Tamoxifen stimulates cancellous bone formation in long bones of female mice</article-title><source>Endocrinology</source><volume>146</volume><fpage>1060</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1210/en.2004-1114</pub-id><pub-id pub-id-type="pmid">15576459</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Powles</surname> <given-names>TJ</given-names></name><name><surname>Hickish</surname> <given-names>T</given-names></name><name><surname>Kanis</surname> <given-names>JA</given-names></name><name><surname>Tidy</surname> <given-names>A</given-names></name><name><surname>Ashley</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="1996">1996</year><article-title>Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women</article-title><source>Journal of Clinical Oncology</source><volume>14</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1200/JCO.1996.14.1.78</pub-id><pub-id pub-id-type="pmid">8558225</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quaedackers</surname> <given-names>ME</given-names></name><name><surname>Van Den Brink</surname> <given-names>CE</given-names></name><name><surname>Wissink</surname> <given-names>S</given-names></name><name><surname>Schreurs</surname> <given-names>RH</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name><name><surname>Van Der Saag</surname> <given-names>PT</given-names></name><name><surname>Van Der Burg</surname> <given-names>BB</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>4-hydroxytamoxifen trans-represses nuclear factor-kappa B activity in human osteoblastic U2-OS cells through estrogen receptor (ER)alpha, and not through ER beta</article-title><source>Endocrinology</source><volume>142</volume><fpage>1156</fpage><lpage>1166</lpage><pub-id pub-id-type="doi">10.1210/endo.142.3.8003</pub-id><pub-id pub-id-type="pmid">11181531</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revankar</surname> <given-names>CM</given-names></name><name><surname>Cimino</surname> <given-names>DF</given-names></name><name><surname>Sklar</surname> <given-names>LA</given-names></name><name><surname>Arterburn</surname> <given-names>JB</given-names></name><name><surname>Prossnitz</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>A transmembrane intracellular estrogen receptor mediates rapid cell signaling</article-title><source>Science</source><volume>307</volume><fpage>1625</fpage><lpage>1630</lpage><pub-id pub-id-type="doi">10.1126/science.1106943</pub-id><pub-id pub-id-type="pmid">15705806</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roepke</surname> <given-names>TA</given-names></name><name><surname>Bosch</surname> <given-names>MA</given-names></name><name><surname>Rick</surname> <given-names>EA</given-names></name><name><surname>Lee</surname> <given-names>B</given-names></name><name><surname>Wagner</surname> <given-names>EJ</given-names></name><name><surname>Seidlova-Wuttke</surname> <given-names>D</given-names></name><name><surname>Wuttke</surname> <given-names>W</given-names></name><name><surname>Scanlan</surname> <given-names>TS</given-names></name><name><surname>Rønnekleiv</surname> <given-names>OK</given-names></name><name><surname>Kelly</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Contribution of a membrane estrogen receptor to the estrogenic regulation of body temperature and energy homeostasis</article-title><source>Endocrinology</source><volume>151</volume><fpage>4926</fpage><lpage>4937</lpage><pub-id pub-id-type="doi">10.1210/en.2010-0573</pub-id><pub-id pub-id-type="pmid">20685867</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanov</surname> <given-names>RA</given-names></name><name><surname>Zeisel</surname> <given-names>A</given-names></name><name><surname>Bakker</surname> <given-names>J</given-names></name><name><surname>Girach</surname> <given-names>F</given-names></name><name><surname>Hellysaz</surname> <given-names>A</given-names></name><name><surname>Tomer</surname> <given-names>R</given-names></name><name><surname>Alpár</surname> <given-names>A</given-names></name><name><surname>Mulder</surname> <given-names>J</given-names></name><name><surname>Clotman</surname> <given-names>F</given-names></name><name><surname>Keimpema</surname> <given-names>E</given-names></name><name><surname>Hsueh</surname> <given-names>B</given-names></name><name><surname>Crow</surname> <given-names>AK</given-names></name><name><surname>Martens</surname> <given-names>H</given-names></name><name><surname>Schwindling</surname> <given-names>C</given-names></name><name><surname>Calvigioni</surname> <given-names>D</given-names></name><name><surname>Bains</surname> <given-names>JS</given-names></name><name><surname>Máté</surname> <given-names>Z</given-names></name><name><surname>Szabó</surname> <given-names>G</given-names></name><name><surname>Yanagawa</surname> <given-names>Y</given-names></name><name><surname>Zhang</surname> <given-names>MD</given-names></name><name><surname>Rendeiro</surname> <given-names>A</given-names></name><name><surname>Farlik</surname> <given-names>M</given-names></name><name><surname>Uhlén</surname> <given-names>M</given-names></name><name><surname>Wulff</surname> <given-names>P</given-names></name><name><surname>Bock</surname> <given-names>C</given-names></name><name><surname>Broberger</surname> <given-names>C</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Hökfelt</surname> <given-names>T</given-names></name><name><surname>Linnarsson</surname> <given-names>S</given-names></name><name><surname>Horvath</surname> <given-names>TL</given-names></name><name><surname>Harkany</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Molecular interrogation of hypothalamic organization reveals distinct dopamine neuronal subtypes</article-title><source>Nature Neuroscience</source><volume>20</volume><fpage>176</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1038/nn.4462</pub-id><pub-id pub-id-type="pmid">27991900</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Romanovsky</surname> <given-names>AA</given-names></name><name><surname>Ivanov</surname> <given-names>AI</given-names></name><name><surname>Shimansky</surname> <given-names>YP</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality</article-title><source>Journal of Applied Physiology</source><volume>92</volume><fpage>2667</fpage><lpage>2679</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.01173.2001</pub-id><pub-id pub-id-type="pmid">12015388</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rondón-Lagos</surname> <given-names>M</given-names></name><name><surname>Villegas</surname> <given-names>V</given-names></name><name><surname>Rangel</surname> <given-names>N</given-names></name><name><surname>Sánchez</surname> <given-names>M</given-names></name><name><surname>Zaphiropoulos</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Tamoxifen resistance: emerging molecular targets</article-title><source>International Journal of Molecular Sciences</source><volume>17</volume><elocation-id>1357</elocation-id><pub-id pub-id-type="doi">10.3390/ijms17081357</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sá</surname> <given-names>SI</given-names></name><name><surname>Fonseca</surname> <given-names>BM</given-names></name><name><surname>Teixeira</surname> <given-names>N</given-names></name><name><surname>Madeira</surname> <given-names>MD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Induction and subcellular redistribution of progesterone receptor A and B by tamoxifen in the hypothalamic ventromedial neurons of young adult female wistar rats</article-title><source>Molecular and Cellular Endocrinology</source><volume>420</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2015.11.015</pub-id><pub-id pub-id-type="pmid">26597778</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname> <given-names>K</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Yan</surname> <given-names>X</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Xu</surname> <given-names>P</given-names></name><name><surname>Hinton</surname> <given-names>AO</given-names></name><name><surname>Shu</surname> <given-names>G</given-names></name><name><surname>Yu</surname> <given-names>L</given-names></name><name><surname>Tong</surname> <given-names>Q</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Visualizing estrogen receptor-α-expressing neurons using a new ERα-ZsGreen reporter mouse line</article-title><source>Metabolism</source><volume>65</volume><fpage>522</fpage><lpage>532</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2015.12.011</pub-id><pub-id pub-id-type="pmid">26975544</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname> <given-names>K</given-names></name><name><surname>Tsuda</surname> <given-names>MC</given-names></name><name><surname>Musatov</surname> <given-names>S</given-names></name><name><surname>Sakamoto</surname> <given-names>T</given-names></name><name><surname>Ogawa</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Differential effects of site-specific knockdown of estrogen receptor α in the medial amygdala, medial pre-optic area, and ventromedial nucleus of the hypothalamus on sexual and aggressive behavior of male mice</article-title><source>European Journal of Neuroscience</source><volume>37</volume><fpage>1308</fpage><lpage>1319</lpage><pub-id pub-id-type="doi">10.1111/ejn.12131</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saunders</surname> <given-names>A</given-names></name><name><surname>Macosko</surname> <given-names>EZ</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Goldman</surname> <given-names>M</given-names></name><name><surname>Krienen</surname> <given-names>FM</given-names></name><name><surname>de Rivera</surname> <given-names>H</given-names></name><name><surname>Bien</surname> <given-names>E</given-names></name><name><surname>Baum</surname> <given-names>M</given-names></name><name><surname>Bortolin</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Goeva</surname> <given-names>A</given-names></name><name><surname>Nemesh</surname> <given-names>J</given-names></name><name><surname>Kamitaki</surname> <given-names>N</given-names></name><name><surname>Brumbaugh</surname> <given-names>S</given-names></name><name><surname>Kulp</surname> <given-names>D</given-names></name><name><surname>McCarroll</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Molecular diversity and specializations among the cells of the adult mouse brain</article-title><source>Cell</source><volume>174</volume><fpage>1015</fpage><lpage>1030</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.07.028</pub-id><pub-id pub-id-type="pmid">30096299</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Scalzo</surname> <given-names>RL</given-names></name><name><surname>Foright</surname> <given-names>RM</given-names></name><name><surname>Hull</surname> <given-names>SE</given-names></name><name><surname>Knaub</surname> <given-names>LA</given-names></name><name><surname>Johnson-Murguia</surname> <given-names>S</given-names></name><name><surname>Kinanee</surname> <given-names>F</given-names></name><name><surname>Kaplan</surname> <given-names>J</given-names></name><name><surname>Freije</surname> <given-names>B</given-names></name><name><surname>Verzosa</surname> <given-names>G</given-names></name><name><surname>Houck</surname> <given-names>JA</given-names></name><name><surname>Johnson</surname> <given-names>G</given-names></name><name><surname>Zhang</surname> <given-names>AMY</given-names></name><name><surname>Johnson</surname> <given-names>JD</given-names></name><name><surname>MacLean</surname> <given-names>PS</given-names></name><name><surname>Reusch</surname> <given-names>JEB</given-names></name><name><surname>Wright-Hobart</surname> <given-names>S</given-names></name><name><surname>Wellberg</surname> <given-names>EA</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Breast Cancer endocrine therapy exhausts adipocyte progenitors promoting weight gain and glucose intolerance</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2020.08.21.259440</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shughrue</surname> <given-names>PJ</given-names></name><name><surname>Lane</surname> <given-names>MV</given-names></name><name><surname>Merchenthaler</surname> <given-names>I</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system</article-title><source>The Journal of Comparative Neurology</source><volume>388</volume><fpage>507</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1002/(SICI)1096-9861(19971201)388:4&lt;507::AID-CNE1&gt;3.0.CO;2-6</pub-id><pub-id pub-id-type="pmid">9388012</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Slee</surname> <given-names>P</given-names></name><name><surname>De Vos</surname> <given-names>D</given-names></name><name><surname>Chapman</surname> <given-names>D</given-names></name><name><surname>Stevenson</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>The bioavailability of tamoplex (tamoxifen)</article-title><source>Pharmaceutisch Weekblad</source><volume>10</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1007/BF01966431</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starnes</surname> <given-names>LM</given-names></name><name><surname>Downey</surname> <given-names>CM</given-names></name><name><surname>Boyd</surname> <given-names>SK</given-names></name><name><surname>Jirik</surname> <given-names>FR</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Increased bone mass in male and female mice following tamoxifen administration</article-title><source>Genesis</source><volume>45</volume><fpage>229</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1002/dvg.20294</pub-id><pub-id pub-id-type="pmid">17417806</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stearns</surname> <given-names>V</given-names></name><name><surname>Ullmer</surname> <given-names>L</given-names></name><name><surname>Lopez</surname> <given-names>JF</given-names></name><name><surname>Smith</surname> <given-names>Y</given-names></name><name><surname>Isaacs</surname> <given-names>C</given-names></name><name><surname>Hayes</surname> <given-names>DF</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Hot flushes</article-title><source>The Lancet</source><volume>360</volume><fpage>1851</fpage><lpage>1861</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(02)11774-0</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stuart</surname> <given-names>T</given-names></name><name><surname>Butler</surname> <given-names>A</given-names></name><name><surname>Hoffman</surname> <given-names>P</given-names></name><name><surname>Hafemeister</surname> <given-names>C</given-names></name><name><surname>Papalexi</surname> <given-names>E</given-names></name><name><surname>Mauck</surname> <given-names>WM</given-names></name><name><surname>Hao</surname> <given-names>Y</given-names></name><name><surname>Stoeckius</surname> <given-names>M</given-names></name><name><surname>Smibert</surname> <given-names>P</given-names></name><name><surname>Satija</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Comprehensive integration of Single-Cell data</article-title><source>Cell</source><volume>177</volume><fpage>1888</fpage><lpage>1902</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.05.031</pub-id><pub-id pub-id-type="pmid">31178118</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeo</surname> <given-names>T</given-names></name><name><surname>Sakuma</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Diametrically opposite effects of estrogen on the excitability of female rat medial and lateral preoptic neurons with axons to the midbrain locomotor region</article-title><source>Neuroscience Research</source><volume>22</volume><fpage>73</fpage><lpage>80</lpage><pub-id pub-id-type="doi">10.1016/0168-0102(95)00885-W</pub-id><pub-id pub-id-type="pmid">7792083</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname> <given-names>RT</given-names></name><name><surname>Wakley</surname> <given-names>GK</given-names></name><name><surname>Hannon</surname> <given-names>KS</given-names></name><name><surname>Bell</surname> <given-names>NH</given-names></name></person-group><year iso-8601-date="1988">1988</year><article-title>Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats</article-title><source>Endocrinology</source><volume>122</volume><fpage>1146</fpage><lpage>1150</lpage><pub-id pub-id-type="doi">10.1210/endo-122-3-1146</pub-id><pub-id pub-id-type="pmid">3342747</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Veen</surname> <given-names>JE</given-names></name><name><surname>Kammel</surname> <given-names>LG</given-names></name><name><surname>Bunda</surname> <given-names>PC</given-names></name><name><surname>Shum</surname> <given-names>M</given-names></name><name><surname>Reid</surname> <given-names>MS</given-names></name><name><surname>Massa</surname> <given-names>MG</given-names></name><name><surname>Arneson</surname> <given-names>D</given-names></name><name><surname>Park</surname> <given-names>JW</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Joseph</surname> <given-names>AM</given-names></name><name><surname>Hrncir</surname> <given-names>H</given-names></name><name><surname>Liesa</surname> <given-names>M</given-names></name><name><surname>Arnold</surname> <given-names>AP</given-names></name><name><surname>Yang</surname> <given-names>X</given-names></name><name><surname>Correa</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Hypothalamic estrogen receptor alpha establishes a sexually dimorphic regulatory node of energy expenditure</article-title><source>Nature Metabolism</source><volume>2</volume><fpage>351</fpage><lpage>363</lpage><pub-id pub-id-type="doi">10.1038/s42255-020-0189-6</pub-id><pub-id pub-id-type="pmid">32377634</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vehmanen</surname> <given-names>L</given-names></name><name><surname>Elomaa</surname> <given-names>I</given-names></name><name><surname>Blomqvist</surname> <given-names>C</given-names></name><name><surname>Saarto</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status</article-title><source>Journal of Clinical Oncology</source><volume>24</volume><fpage>675</fpage><lpage>680</lpage><pub-id pub-id-type="doi">10.1200/JCO.2005.02.3515</pub-id><pub-id pub-id-type="pmid">16446340</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wade</surname> <given-names>GN</given-names></name><name><surname>Heller</surname> <given-names>HW</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>Tamoxifen mimics the effects of estradiol on food intake, body weight, and body composition in rats</article-title><source>American Journal of Physiology-Regulatory, Integrative and Comparative Physiology</source><volume>264</volume><fpage>R1219</fpage><lpage>R1223</lpage><pub-id pub-id-type="doi">10.1152/ajpregu.1993.264.6.R1219</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waltman</surname> <given-names>L</given-names></name><name><surname>van Eck</surname> <given-names>NJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>A smart local moving algorithm for large-scale modularity-based community detection</article-title><source>The European Physical Journal B</source><volume>86</volume><elocation-id>471</elocation-id><pub-id pub-id-type="doi">10.1140/epjb/e2013-40829-0</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>T</given-names></name><name><surname>Inoue</surname> <given-names>S</given-names></name><name><surname>Ogawa</surname> <given-names>S</given-names></name><name><surname>Ishii</surname> <given-names>Y</given-names></name><name><surname>Hiroi</surname> <given-names>H</given-names></name><name><surname>Ikeda</surname> <given-names>K</given-names></name><name><surname>Orimo</surname> <given-names>A</given-names></name><name><surname>Muramatsu</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors alpha and beta</article-title><source>Biochemical and Biophysical Research Communications</source><volume>236</volume><fpage>140</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1006/bbrc.1997.6915</pub-id><pub-id pub-id-type="pmid">9223441</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname> <given-names>ME</given-names></name><name><surname>Mook</surname> <given-names>D</given-names></name><name><surname>Graves</surname> <given-names>F</given-names></name><name><surname>Felger</surname> <given-names>J</given-names></name><name><surname>Bielsky</surname> <given-names>IF</given-names></name><name><surname>Wallen</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal Axis in female monkeys</article-title><source>Endocrine</source><volume>22</volume><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1385/ENDO:22:3:305</pub-id><pub-id pub-id-type="pmid">14709804</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Windahl</surname> <given-names>SH</given-names></name><name><surname>Andersson</surname> <given-names>G</given-names></name><name><surname>Gustafsson</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>Elucidation of estrogen receptor function in bone with the use of mouse models</article-title><source>Trends in Endocrinology &amp; Metabolism</source><volume>13</volume><fpage>195</fpage><lpage>200</lpage><pub-id pub-id-type="doi">10.1016/S1043-2760(02)00594-5</pub-id><pub-id pub-id-type="pmid">12185665</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Q</given-names></name><name><surname>Tam</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>SA</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Fate mapping Nkx2.1-lineage cells in the mouse telencephalon</article-title><source>The Journal of Comparative Neurology</source><volume>506</volume><fpage>16</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1002/cne.21529</pub-id><pub-id pub-id-type="pmid">17990269</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Nedungadi</surname> <given-names>TP</given-names></name><name><surname>Zhu</surname> <given-names>L</given-names></name><name><surname>Sobhani</surname> <given-names>N</given-names></name><name><surname>Irani</surname> <given-names>BG</given-names></name><name><surname>Davis</surname> <given-names>KE</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Zou</surname> <given-names>F</given-names></name><name><surname>Gent</surname> <given-names>LM</given-names></name><name><surname>Hahner</surname> <given-names>LD</given-names></name><name><surname>Khan</surname> <given-names>SA</given-names></name><name><surname>Elias</surname> <given-names>CF</given-names></name><name><surname>Elmquist</surname> <given-names>JK</given-names></name><name><surname>Clegg</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Distinct hypothalamic neurons mediate estrogenic effects on energy homeostasis and reproduction</article-title><source>Cell Metabolism</source><volume>14</volume><fpage>453</fpage><lpage>465</lpage><pub-id pub-id-type="doi">10.1016/j.cmet.2011.08.009</pub-id><pub-id pub-id-type="pmid">21982706</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>QA</given-names></name><name><surname>Tao</surname> <given-names>C</given-names></name><name><surname>Vishvanath</surname> <given-names>L</given-names></name><name><surname>Shao</surname> <given-names>M</given-names></name><name><surname>McDonald</surname> <given-names>JG</given-names></name><name><surname>Gupta</surname> <given-names>RK</given-names></name><name><surname>Scherer</surname> <given-names>PE</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Impact of tamoxifen on adipocyte lineage tracing: inducer of adipogenesis and prolonged nuclear translocation of cre recombinase</article-title><source>Molecular Metabolism</source><volume>4</volume><fpage>771</fpage><lpage>778</lpage><pub-id pub-id-type="doi">10.1016/j.molmet.2015.08.004</pub-id><pub-id pub-id-type="pmid">26629402</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yellen</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism</article-title><source>Journal of Cell Biology</source><volume>217</volume><fpage>2235</fpage><lpage>2246</lpage><pub-id pub-id-type="doi">10.1083/jcb.201803152</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Veldhuis-Vlug</surname> <given-names>AG</given-names></name><name><surname>Su</surname> <given-names>Y</given-names></name><name><surname>Foppen</surname> <given-names>E</given-names></name><name><surname>van der Eerden</surname> <given-names>BC</given-names></name><name><surname>Koedam</surname> <given-names>M</given-names></name><name><surname>Bravenboer</surname> <given-names>N</given-names></name><name><surname>Kalsbeek</surname> <given-names>A</given-names></name><name><surname>Boelen</surname> <given-names>A</given-names></name><name><surname>Fliers</surname> <given-names>E</given-names></name><name><surname>Bisschop</surname> <given-names>PH</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Effects of chronic estrogen administration in the ventromedial nucleus of the hypothalamus (VMH) on fat and bone metabolism in ovariectomized rats</article-title><source>Endocrinology</source><volume>157</volume><fpage>4930</fpage><lpage>4942</lpage><pub-id pub-id-type="doi">10.1210/en.2016-1481</pub-id><pub-id pub-id-type="pmid">27911148</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Reis</surname> <given-names>F</given-names></name><name><surname>He</surname> <given-names>Y</given-names></name><name><surname>Park</surname> <given-names>JW</given-names></name><name><surname>DiVittorio</surname> <given-names>JR</given-names></name><name><surname>Sivakumar</surname> <given-names>N</given-names></name><name><surname>van Veen</surname> <given-names>JE</given-names></name><name><surname>Maesta-Pereira</surname> <given-names>S</given-names></name><name><surname>Shum</surname> <given-names>M</given-names></name><name><surname>Nichols</surname> <given-names>I</given-names></name><name><surname>Massa</surname> <given-names>MG</given-names></name><name><surname>Anderson</surname> <given-names>S</given-names></name><name><surname>Paul</surname> <given-names>K</given-names></name><name><surname>Liesa</surname> <given-names>M</given-names></name><name><surname>Ajijola</surname> <given-names>OA</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Adhikari</surname> <given-names>A</given-names></name><name><surname>Correa</surname> <given-names>SM</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Estrogen-sensitive medial preoptic area neurons coordinate torpor in mice</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6378</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20050-1</pub-id><pub-id pub-id-type="pmid">33311503</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63333.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>McCarthy</surname><given-names>Margaret M</given-names></name><role>Reviewing Editor</role><aff><institution>University of Maryland School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>McCarthy</surname><given-names>Margaret M</given-names></name><role>Reviewer</role><aff><institution>University of Maryland School of Medicine</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Millions of women endure side effects associated with long-term tamoxifen therapy for prevention of breast cancer recurrence. Your work in the mouse demonstrating that estrogen receptors in specific regions of the brain mediate many of the peripheral effects of tamoxifen provides important insights into the mechanisms by which bone density, body temperature and movement are impacted this therapeutic.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Hypothalamic estrogen receptor alpha mediates key side effects of tamoxifen therapy in mice&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, including Margaret M McCarthy as the Reviewing Editor and Reviewer #1, and the evaluation has been overseen by Catherine Dulac as the Senior Editor.</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>We would like to draw your attention to changes in our revision policy that we have made in response to COVID-19 (https://elifesciences.org/articles/57162). Specifically, when editors judge that a submitted work as a whole belongs in <italic>eLife</italic> but that some conclusions require a modest amount of additional new data, as they do with your paper, we are asking that the manuscript be revised to either limit claims to those supported by data in hand, or to explicitly state that the relevant conclusions require additional supporting data.</p><p>Our expectation is that the authors will eventually carry out the additional experiments and report on how they affect the relevant conclusions either in a preprint on bioRxiv or medRxiv, or if appropriate, as a Research Advance in <italic>eLife</italic>, either of which would be linked to the original paper.</p><p>Summary:</p><p>Tamoxifen is a front line therapy for patients diagnosed with and treated for breast cancer, with many women taking the drug for up to 10 years. Non-compliance is often associated with negative side effects experienced by some women. Relatively little attention is paid to how tamoxifen acts on the brain and this report addresses that directly and specifically by exploiting the power of single cell RNA sequencing of the hypothalamus in both the wildtype and a conditional KO of estrogen receptor alpha mouse. This study was designed to identify neurobiological mechanisms underlying the effects of tamoxifen. Mice were given tamoxifen daily for four weeks. Tamoxifen increased indices of heat dissipation and bone density, while decreasing activity. Tamoxifen also produced complex and widespread changes in gene expression in various cell types, as measured by single cell Drop-seq and gene set enrichment analyses. In neurons, more genes were repressed than induced. These changes were largely ablated by tamoxifen in mice with specific knockout of ERα in the hypothalamus, suggesting that tamoxifen-induced repression of gene expression is mediated by ERα. ERα KO also blocked effects of tamoxifen on heat dissipation, bone density, and activity, suggesting by extension that tamoxifen's affects these variables in least in part via ERα-mediated gene expression.</p><p>Revisions for this paper:</p><p>1) A major theoretical concern was raised by one reviewer: Whether all this detailed observations have any relevance for the human condition is absolutely unknown. In this regard, it would be important to clarify what the authors mean by &quot;tamoxifen therapy&quot;? Of human or of mice? If of humans (which seems to be the scenario), this clearly is not possible to test in mice. Where this work may be relevant actually is the use of tamoxifen in transgenic construct of mouse models. However, the tamoxifen intervention did not mimic that approach. Thus, in the end, it is unclear what this extensive data set reflects regarding the human condition or other issues. It appears the authors are clearly aiming to address Tamoxifen's side effects regarding the human condition. What does it mean to state there are &quot;side-effect&quot; regarding mice? They should change the wording on the specifics as it relates to mice but could discuss the issue in the Discussion as a potential relevance to humans.</p><p>2) The gene expression data are impressive and have the potential to identify specific genes modulated by tamoxifen in an ERα-dependent manner. However, a more explicit description of the key genes in neurons that are differentially expressed in wild-type and ERα KOs in response to tamoxifen would be very useful. This information wasn't clear from the supplementary files, and the volcano plots, while providing pretty Rorschach-like pictures of differential gene expression, provide no specifics about the identity of the genes that are differentially regulated by tamoxifen in wild-type and ERα KOs. From the perspective of drug development, which the authors emphasized in the Introduction, what DEGs would be worth targeting to mitigate the side effects of tamoxifen? Without information about specific DEGs, it's hard to see how the Drop-seq data provide significant insights that could lead to new adjuvant therapies to prevent tamoxifen side effects.</p><p>3) To better understand the effects of Erα KO on gene expression, it would be useful to mention somewhere in the paper the relative abundance and distribution of hypothalamic ERα in the cell types examined (particularly neurons and the various glia types). Do hypothalamic ERβ, GPER, or even PRs contribute to thermoregulation, bone density, or activity and if so, would the authors expect similar interactions with tamoxifen if these receptors were knocked out?</p><p>4) Although the data support that tamoxifen reduces core body temperature and increases tail temperature over the course of many hours during the light cycle, hot flashes in women are characterized by sudden increases in temperature that dissipate within a few minutes. Thus, the authors should be careful in equating these longer-term changes to the more temporally distinct hot flashes and acknowledge this caveat in the Discussion.</p><p>5) “Single-cell expression analysis was unable to detect a significant decrease of <italic>Esr1</italic> expression in any cell type of <italic>Esr1<sup>cKO</sup></italic> mice, but clearly demonstrated that the NK2 homeobox transcription factor <italic>Nkx2-1</italic> was enriched in neurons and in ependymal cells” – if I am understanding this correctly it means there is no evidence that <italic>Esr1</italic> was in fact deleted in neurons and ependymal cells. This seems problematic, can the authors provide more of an explanation and some assurances that the model is indeed what they say it is?</p><p>6) “29,807 cells (8,220 from n = 3 vehicle treated mice, 21,587 from n = 5 tamoxifen treated mice)” – can the authors address whether it is problematic that they have almost 3 times as many cells from tamoxifen treated mice as controls.</p><p>7) It wasn't clear how Figure 5—figure supplement 3 supports the statement, &quot;Together these data indicate that hypothalamic expression of ERα is required for a large proportion of the gene expression changes normally induced by tamoxifen, including many functional pathways and those controlling neuronal activity and estrogen targets in many cell types and neuronal subtypes.&quot;. The graphs seem to indicate little overlap between wild-type and <italic>Esr1</italic> KO.</p><p>Title:</p><p>In light of the comments of the reviewer, the authors might consider removing &quot;side effects&quot; from the title.</p><p>Revisions expected in follow-up work:</p><p>Revisions needed are addressed above and are largely along the lines of clarification and reframing the findings in terms of whether they are or are not clinically relevant</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63333.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Revisions for this paper:</p><p>1) A major theoretical concern was raised by one reviewer: Whether all this detailed observations have any relevance for the human condition is absolutely unknown. In this regard, it would be important to clarify what the authors mean by &quot;tamoxifen therapy&quot;? Of human or of mice? If of humans (which seems to be the scenario), this clearly is not possible to test in mice. Where this work may be relevant actually is the use of tamoxifen in transgenic construct of mouse models. However, the tamoxifen intervention did not mimic that approach. Thus, in the end, it is unclear what this extensive data set reflects regarding the human condition or other issues. It appears the authors are clearly aiming to address Tamoxifen's side effects regarding the human condition. What does it mean to state there are &quot;side-effect&quot; regarding mice? They should change the wording on the specifics as it relates to mice but could discuss the issue in the Discussion as a potential relevance to humans.</p></disp-quote><p>This point is well taken. The revision now reserves the use of the word “therapy” for when discussing tamoxifen therapy only in humans. To make this distinction clear, and to appropriately limit interpretations of our data, we have changed the title to “Estrogen receptor alpha in the brain mediates tamoxifen induced changes in physiology in mice” and removed the word “therapy” from our experimental design, reporting of results, and the majority of the Discussion. We do discuss tamoxifen therapy in humans when setting up the problem in the Introduction and again at the end of the Discussion to highlight a potential relevance to humans, as suggested.</p><disp-quote content-type="editor-comment"><p>2) The gene expression data are impressive and have the potential to identify specific genes modulated by tamoxifen in an ERα-dependent manner. However, a more explicit description of the key genes in neurons that are differentially expressed in wild-type and Erα KOs in response to tamoxifen would be very useful. This information wasn't clear from the supplementary files, and the volcano plots, while providing pretty Rorschach-like pictures of differential gene expression, provide no specifics about the identity of the genes that are differentially regulated by tamoxifen in wild-type and Erα KOs. From the perspective of drug development, which the authors emphasized in the Introduction, what DEGs would be worth targeting to mitigate the side effects of tamoxifen? Without information about specific DEGs, it's hard to see how the Drop-seq data provide significant insights that could lead to new adjuvant therapies to prevent tamoxifen side effects.</p></disp-quote><p>We thank the reviewer for these important clarifying comments about the Drop-seq data. Our initial submission was focused on the general effects of tamoxifen on gene expression in the different cell types examined. As stated in the text, this indicates that neurons and ependymal cells are most transcriptionally responsive to tamoxifen administration. We went on to highlight pathways (neuropeptide signaling, oxidative phosphorylation, glycolysis) that are important for neuronal function and are coordinately downregulated by tamoxifen in wild-type neurons but not in cKO neurons. Nevertheless, we can see how a lack of individual gene names could seem obfuscating or unsatisfying.</p><p>For the pathway analyses, we now highlight genes in Figure 4C, identifying individual genes within the significant pathways that may be potential candidates for follow up studies. Furthermore, we reasoned that if individual differentially expressed genes are potential regulators of tamoxifen’s physiological effects, then they are likely to be discordantly regulated in the wild-type vs. cKO hypothalamus-POA. We now provide a complete list of genes that are significantly (adj. <italic>p</italic>&lt;0.05) differentially expressed in wild-type cells treated with tamoxifen vs. vehicle (Supplementary file 1I and J). The supplementary files also provide corresponding differential expression data for these same genes in cKO cells. Although this information is available in the supplementary files, we highlighted some of these genes in Figure 5D, which simultaneously illustrates how individual genes are regulated by tamoxifen in wild-type cells and cKO cells.</p><disp-quote content-type="editor-comment"><p>3) To better understand the effects of ERα KO on gene expression, it would be useful to mention somewhere in the paper the relative abundance and distribution of hypothalamic ERα in the cell types examined (particularly neurons and the various glia types). Do hypothalamic ERβ, GPER, or even PRs contribute to thermoregulation, bone density, or activity and if so, would the authors expect similar interactions with tamoxifen if these receptors were knocked out?</p></disp-quote><p>We agree it is important to understand if PR or other ERs contribute to the changes induced by tamoxifen. The relative abundance and distribution of hypothalamic ERα in the various cell types is highlighted in Figure 3B, which shows the percent of cells within each cell type in which we detected <italic>Esr1, Esr2, Pgr,</italic> and <italic>Gper1</italic>. The distribution of <italic>Esr1, Esr2, Pgr,</italic> and <italic>Gper1</italic> are also now provided for neuronal subtypes in Figure 4B (these are now included as the first four genes on the x-axis).</p><p>Although we have only examined the effect of ERα conditional KO on body temperature, bone density and physical activity, it is possible that ERα expressed outside of the <italic>Nkx2-1</italic> lineage or other receptors beyond than ERα may also be involved. The revised manuscript acknowledges this possibility in several sections of the manuscript, as outlined below:</p><p>a) We examine <italic>Esr1, Esr2, Pgr,</italic> and <italic>Gper1</italic> expression in our data (Figure 3B, Figure 4B).</p><p>b) We cite studies that show effects of other receptors on thermoregulation in the Discussion: Opas et al., 2009, Roepke et al., 2010), physical activity: Ogawa et al., 2003), and bone: Windahl et al., 2002, Lindberg et al., 2002, Roepke et al., 2010).</p><p>c) This more comprehensive evaluation of our data and the literature sets up the conclusion that “ERα signaling within the <italic>Nkx2-1</italic> lineage as a major mediator” (not necessarily the only mediator) “of the effects of tamoxifen on thermoregulation, physical activity, and bone homeostasis”.</p><disp-quote content-type="editor-comment"><p>4) Although the data support that tamoxifen reduces core body temperature and increases tail temperature over the course of many hours during the light cycle, hot flashes in women are characterized by sudden increases in temperature that dissipate within a few minutes. Thus, the authors should be careful in equating these longer-term changes to the more temporally distinct hot flashes and acknowledge this caveat in the Discussion.</p></disp-quote><p>Thank you for pointing out this important distinction. Along with the distinction between tamoxifen therapy in humans and tamoxifen treatment in mice, any effects on hot flashes are quite distinct from effects on thermoregulation. (We think that vasomotor symptoms in women are a consequence of changes in thermoregulation that accompany menopause but that is not the point of the current manuscript.) We have acknowledged this caveat in the Discussion and drawn parallels between our findings and the effects of ovariectomy in rodents, which also leads to higher tail temperature and sometimes lower core temperature.</p><p>“However, it is important to acknowledge that the sustained increase in tail skin temperature observed here and in other animal models (Kobayashi et al., 2000, Padilla et al., 2018) does not fully reflect the episodic nature of hot flashes in humans.”</p><disp-quote content-type="editor-comment"><p>5) “Single-cell expression analysis was unable to detect a significant decrease of Esr1 expression in any cell type of Esr1<sup>cKO</sup> mice, but clearly demonstrated that the NK2 homeobox transcription factor Nkx2-1 was enriched in neurons and in ependymal cells” – if I am understanding this correctly it means there is no evidence that Esr1 was in fact deleted in neurons and ependymal cells. This seems problematic, can the authors provide more of an explanation and some assurances that the model is indeed what they say it is?</p></disp-quote><p>As the reviewer astutely pointed out, we unfortunately did not detect a significant reduction of <italic>Esr1</italic> transcript in any cell types. A noted limitation of scRNA-seq is the loss of statistical power as cells are divided into individual clusters and analyzed. This loss of power particularly affects analysis of low expression transcripts like <italic>Esr1</italic>. Therefore, we examined ERα protein expression by immunohistochemistry in wild-type and cKO mice, which appears in Figure 5A. Indeed, ERα immunoreactivity is absent in the VMH, ARC, and POA of the conditional KO model, as shown in Figure 5A and in previous publications from our group (Correa et al., 2015, Herber et al., 2019). Nevertheless, we agree that showing the gene expression data for <italic>Esr1</italic> is important, despite the fact that we observed no significant decrease. We have now added this analysis as Figure 5—figure supplement 1A as fold changes in <italic>Esr1</italic> expression in cKO compared to wild-type mice, showing essentially no change.</p><disp-quote content-type="editor-comment"><p>6) “29,807 cells (8,220 from n = 3 vehicle treated mice, 21,587 from n = 5 tamoxifen treated mice)” – can the authors address whether it is problematic that they have almost 3 times as many cells from tamoxifen treated mice as controls.</p></disp-quote><p>This is a very important point, and we thank the reviewer for highlighting it. The imbalance in the number of cells was a consequence one control mouse dying just before completion of the treatment timeline. With the extra space in our drop-seq pipeline, we included an extra tamoxifen-treated mouse that was treated concurrently and available at the time. Like the reviewer, we were trepidatious about analyzing an unequal number of vehicle and control mice, however, the authors of the scRNA-seq package that we used (Seurat) claim that imbalanced cell numbers are not inherently a problem (<ext-link ext-link-type="uri" xlink:href="https://github.com/satijalab/seurat/issues/1325">https://github.com/satijalab/seurat/issues/1325</ext-link>).</p><p>Nevertheless, to address this concern that we share with the reviewer, we randomly sampled our groups after initial quality filtering such that each group would contain 8,220 cells. As shown in Author response images 1 and 2, the results of the down-sampled analyses mirror the results found in the initial submission with respect to: Cell types identified, distribution of ERs, the unique sensitivity of neurons and ependymal cells to tamoxifen, the effect of tamoxifen on functional pathways, and the discordant effects of tamoxifen on wild-type and cKO cells. Together these data indicate that the imbalance in cell number did not affect the outcome of the analyses, and so we believe that it is appropriate to leave the initially submitted analysis, which has more statistical power, in the manuscript.</p><fig id="sa2fig1"><label>Author response image 1.</label><caption><title>Downsampled re-analysis of scRNA-Seq: all treatment groups normalized to exactly 8,220 cells after initial quality filtering.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-resp-fig1-v1.tif"/></fig><fig id="sa2fig2"><label>Author response image 2.</label><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63333-resp-fig2-v1.tif"/></fig><disp-quote content-type="editor-comment"><p>7) It wasn't clear how Figure 5—figure supplement 3 supports the statement, &quot;Together these data indicate that hypothalamic expression of ERα is required for a large proportion of the gene expression changes normally induced by tamoxifen, including many functional pathways and those controlling neuronal activity and estrogen targets in many cell types and neuronal subtypes.&quot;. The graphs seem to indicate little overlap between wild-type and Esr1KO.</p></disp-quote><p>We thank the reviewer for pointing out the confusing manner in which we described our data. As the reviewer correctly points out, there is little overlap between wild-type and <italic>Esr1</italic>cKO cells in response to tamoxifen, and this is the point we intended to convey. The Results section explaining Figure 5 and its supplements has been re-written for clarity. Furthermore, labeling in Figure 5 and its supplements has been re-worked to convey the point the reviewer makes.</p><disp-quote content-type="editor-comment"><p>Title:</p><p>In light of the comments of the reviewer, the authors might consider removing &quot;side effects&quot; from the title.</p></disp-quote><p>We have changed the title to “Estrogen receptor alpha in the brain mediates tamoxifen induced changes in physiology in mice”.</p></body></sub-article></article>